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ABSTRACT
During normal pregnancy, the fetus is not rejected by the maternal immune 
system despite bearing paternal MHO antigen. It has been proposed that this 
is due to the local production of immunoregulatory factors by the maternal 
decidua. This study was designed to investigate immunosuppressive factors 
derived from early human decidua.
In the first part of the study, assays were standardised in order to monitor the 
immunoregulatory activity of factors derived from human decidua. These 
included mitogen induced lymphocyte proliferation, mixed lymphocyte culture, 
and the proliferation of human monocytic and T lymphoid cell lines.
Using these assays, two fractions from the FPLC separation of the 10-100 
KDa crude decidual supernatant with immunosuppressive activity have been
identified and partially characterised. One contained molecules of 183 KDa
under non-reducing SDS-PAGE analysis, and 70 and 29 KDa under reducing
conditions (large molecular weight fraction; LMWF). Another had molecules
of 7-14 KDa under non-reducing conditions (small molecular weight fraction;
SMWF). Both of them inhibited mitogen-induced lymphoproliferation and the
mixed lymphocyte reaction. In addition they inhibited the growth of a
monocytic cell line (Mono Mac 6), but not that of a T lymphoblastic cell line
(Jurkat E6.1). The suppression of cellular growth by the LMWF, but not the
SMWF, was due to the arrest of the cells in the G0/G1 phase of the cell
cycle. Neither fraction affected the expression of MHC class II on Mono
Mac 6 cells.
The decidua-derived suppressive factors showed some similarity to human
transforming growth factor type p (hTGFp), but their activity could not be
eliminated by neutralising antibodies to hTGFpt and p2. In contrast to the
decidua factors, hTGFpt was able to significantly suppress the expression of
MHC class II molecules. In addition, acidification of LMWF decreased their
suppressive activity, whereas others have shown that similar treatment of
TGFp isolated from decidua enhanced its activity. Although some similarity to 
human decidua-associated protein
hDP200 could be demonstrated with LMWF, IgG-like molecules could not be
demonstrated in the latter. A low molecular weight protein with
immunosuppressive activity-PP14- has been demonstrated in human
decidua. Despite similarity, the SMWF clearly showed a distinct M.w 
pattern
distribution to PP14 when analysed by Western blot. This suggests that 
SMWF was not PP14.
In the final part of the study, the supernatants of decidual mononuclear cell cultures 
(non-fractionated or fractionated) were used to investigate the cells which may 
produce the factors. The preliminary results suggest that non-leukocytic decidua 
cells are unlikely to be responsible for the activity. Either T lymphocytes or NK cells 
are the more likely source, as the suppressive activity was largely increased in 
populations enriched for these cells, and concanavalin A enhanced their 
suppressive activity. However, the precise cellular source of these factors needs 
to be elucidated further.
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CHAPTER 1
INTRODUCTION
1.1. RELATIONSHIP BETWEEN THE DECIDUA AND THE 
FETUS DURING EARLY PREGNANCY
1.1.1. DEVELOPMENT OF THE DECIDUA
In the late stage of the menstrual cycle, the uterine endometrium proliferates 
and secretes under the influence of female hormones: oestrogens and 
progesterone.The thickened endometrium is known as^ecidua. If fertilization 
and implantation does not occur, the swollen endometrium undergoes 
necrosis and is shed. However, if these events do occur, the endometrium 
becomes thicker, spongier, and more vascular, forming specialised 
gestational tissue, known as pregnant decidua (In this thesis the term 
"decidua" is used as a synonym for pregnant decidua). Throughout gestation, 
the decidua maintains direct physical contact with the developing fetus, 
providing the means by which it absorbs nourishment from the mother. 
Decidua by itself is composed of three distinct regions classified according to 
their position relative to the fetus. The decidual tissue beneath the site of 
implantation is called the decidua basal is; that lying over the fetus is known 
as the decidua capsularis; and the still unoccupied part is known as the 
decidua vera (Pritchard etaL, 1985). The decidua basal is is of particular 
interest since it forms the maternal part of the hemochorial placenta (see 
below). Fig 1.1-1 depicts a picture of early pregnant human decidua in the 
uterus.
Decidua 
vera ^
Uterine
cavity
Chorion
laeve
Decidua 
capsularis
Yolk sac
Chorion
frondosum
Decidua
basalis
Amnionic sac
Fig. 1.1-1. Early pregnant human decidua in uterus containing an 
embryo (Adopted from Pritchard et al, 1985).
1 ), Decidua is composed of three portions; basalis, capsularis, and vera.
2). The uterine cavity is bounded by decidua vera and capsularis during the 
early months of pregnancy. By the fourth month, this cavity is filled by the 
growth sac.
3). Chorion frondsum (chorionic villi) proliferate into the decidua basalis; 
and atrophic chorion laeve are within^decidua capsularis.
1.1.2 FORMATION OF THE FETUS.
The fetus develops as a result oMertilisatlon of a mature oocyte by a 
spermatozoan in the middle of the menstrual cycle. Both the spermatozoan 
and oocyte contain only half the normal complement of chromosomes as a 
result of a meiotic division during their maturation. Following the fusion of a 
spermatozoan and an oocyte in the fallopian tube, the two sets of 23 
chromosomes unite together, resulting in a cell containing the normal diploid 
complement of 46 chromosomes, half being derived from the mother, and half 
from the father.
The fertilized oocyte begins to divide in the fallopian tube, and soon forms a 
solid clump of cells with an amniotic cavity appearing amongst them. The 
latter is termed the blastocyte, which is the precursor of the fetus. The 
blastocyte continues to grow and divide in the uterus vera (Pritchard etal., 
1985).
1.1.3. DEVELOPMENT OF THE HEMOCHORIAL PLACENTA
The blastocyst implants in the superficial layer of the decidua. Its outermost 
cells, i.e. the trophoblast, secrete digestive enzymes which break down the 
surrounding cellular structure of the decidua. Gradually the blastocyst burys 
itself completely within the decidua basalis.
After the invasion of the blastocyte, the trophoblast and mesoderm become 
organised into chorionic villi. Each villus is composed of a thick outer layer of 
syncytiotrophoblast {multinucleated cells; in which the nuclei are scattered in 
a mass of cytoplasm) with trophoblastic lacunae, an underlying layer of 
cytotrophoblast (mononuclear) and a central core of mesenchyme.
Meanwhile, some cytotrophoblast cells are located in the extravillous space 
and comprise the extra-villous population of the trophoblast. The villi branch 
and form tree-like structures (Fig 1.1-2).
As the trophoblast develops its villi, the decidua basalis grows thicker and 
more vascular. The enlarged maternal vessels surround the villi and connect 
with one another to form a continuous system of vascular, intervillous space. 
As chorionic villi continuously erode the decidua and penetrate the maternal 
capillaries within the decidua basalis, the lacunar clefts become filled with 
maternal blood. Thus, the distinct tissue, hemochorial placenta, is formed; 
and the syncytiotrophoblasts and trophoblasts come into direct contact with 
maternal circulating lymphocytes.
1.1.4. THE ROLE OF MATERNAL-FETAL SURFACE IN THE MAINTENANCE 
OF PREGNANCY
One characteristic of the immune response Is its ability to discriminate 
between "self" and "non-self". Once "foreignness" has been established, the 
immune response proceeds to eliminate the foreign material, including
' ' ' .' .A. . /
g
A
Trophoblastic
lacunae
Mesenchymeof villus
Cytotrophoblast Syncytiotrophoblast
Fig. 1.1-2. Chorionic villi (Adopted from Llewellyn-Jones, 1990).
1). Each villus is composed of syncytiotrophoblast with trophoblastic lacunae, 
cytotrophoblast, and mesoblastic core of villus.
2). The lacunar clefts are filled with maternal blood (which for clarity is not 
shown).
incompatible allografts. An exception occurs in pregnant mothers; they do 
not reject their fetus which carries the father's histocompatibility antigens. So 
far, there is little evidence for a systemic tolerance of the mother to paternal 
alloantigens during pregnancy. Thus, the mechanisms for protection of the 
fetus have been sought locally at the fetal-maternal interface.
1.1.4.1. The regulation of the expression of MHC antigens on trophoblast. 
The fetal membranes are the fetal tissues in closest contact with the maternal 
decidua. The fetal cells in direct contact with maternal blood or tissue are the 
syncytiotrophoblast and cytotrophoblast. The regulation of major 
histocompatibility complex (MHC) antigen expression on these cells is 
thought to be one of the mechanisms involved in the prevention of 
recognition of the semi-allogenic graft by the maternal immune system. The 
regulation includes preventing the expression of class II HLA-D antigens, 
and reducing steady-state levels of mRNA for the Class I MHC genes HLA-A, 
B on both syncytiotrophoblast and cytotrophoblast (review by Hunt J., 1992a, 
1992 b). Instead, one non-classic, class I antigen, HLA-G, has been detected 
on cytotrophoblast. The HLA-G antigen is a non-polymorphic 39 KDa heavy 
chain (smaller than classic MHC I antigens with M.w. of 43 kDa) associated 
with G-microglobulin on the cell surface. According to the  ^missing self  ^
hypothesis, one function of natural killer (NK) cells is to recognise and 
eliminate cells that fail to express self MHC class I molecules. 
Cytotrophoblast do not express polymorphic MHC class I antigens but 
express HLA-G. So, it has been proposed that HLA-G may act to protect the 
trophoblast from attack by maternal NK cells (Reviewed by Johnson, 1993).
Recently, It has been reported that cytotrophoblast is resistant to NK cell 
mediated cytolysis (Loke et al, 1991; Ferry etal, 1991). However, the finding 
that 32-microglobulin deficient mice (also defective in CD4-8+ T cells) are 
capable of reproducing readily with normal litter size (Zilstra et al, 1990) 
suggests that HLA-G may functionally redundant (Reviewed by Johnson, 
1993).
1.1.4.2 The expression of complement-regulatory proteins on trophoblast 
The complement cascade may be activated by the presence of either 
maternal anti-fetal antibody attack or a response to microbial infection at the 
fetal-maternal surface. The human trophoblast express high levels of 
complement regulatory proteins on their surface. These proteins can protect 
trophoblast cells from potential complement-mediated damage. There are 
three kinds of complement-regulatory proteins: (a). CD46. It was previously 
described as trophoblast-leucocyte common (TLX) antigen and membrane 
co-factor protein (MOP), (b). Decay-accelerating factor (DAF, GD55). These 
two act at the level of 03 convertase enzymes which activate 03 to 03b. (c). 
OD59, which inhibits the formation and function of the terminal cytolytic 
membrane attack complex by interacting with 08 and 09 (reviewed by 
Holmes et al, 1992; Johnson, 1993). Thus, these proteins appears to play an 
important role in the maintenance of normal human pregnancy.
1.1.4.3. The maternal immune responses to fetal antigens 
Specific antibodies were found in the serum and placental eluates of 
pregnant female mice. These antibodies eluted from the placentae can 
attach to an eluted placenta, and bind to paternal (but not maternal)
lymphocytes and thymocytes. Antibodies eluated from the placenta were 
able to block Fc receptors of B cells, suppress the mixed lymphocyte reaction 
(MLR) and other T cell function. When injected into maternal strain 
recipients, these antibodies prevent rejection of paternal-strain tumour 
allograft (reviewed by Viosin, 1983). However, agammaglobulinaemic 
patients (lacking blocking antibodies) reproduce normal, it suggests that the 
antibodies are probably the consequence of pregnancy rather than 
important for its maintenance (Riches, personnel communication).
Pregnancy serum also contains more than 30 pregnancy-associated 
proteins. One third of them have been proposed as immunoregulatory 
factors. For instance, pregancy-associated a2-glycoprotein and a-fetoprotein 
were shown to be inhibitory to MLR, and T cell mitogen responses. Sex 
steroid hormones also exerted a inhibitory influence over maternal 
immunological activity (Stimpson, 1983).
1.1.4.4. The role of decidua in the maintenance of preonancv.
Recently, it has been reported that HLA-G could bind to the CD8 molecule 
on T cytotoxic / suppressor lymphocytes (Sanders, 1991). There is some 
evidence that the cytotrophoblast may also express an unusual form of MHO 
class II (Starkey, 1987). Moreover, some minor histocompatibility antigens or 
other polymorphic membrane proteins on the trophoblast may be recognised 
as non-self by the maternal immune cells and subsequently provoke a local 
immune responses (Starkey, 1992).
Recently, it was found that a subset of yS T lymphocytes were considerably 
increased in murine decidua. These maternal T cells can specifically 
recognise trophoblasts and produce IL-2 in a non MHC-restricted fashion. It 
suggests a novel form,of T cell recognition in decidua, although the effector 
functions that result from the trophoblast recognition remain to be determined 
(Heyborne etaL, 1994). The accumulated evidence reveals another possible 
protective mechanism, i.e. the decidua may locally produce soluble factors 
which regulate the maternal response to the cytotrophoblast and the semi- 
allogeneic fetus. For example:
1)! When experimental allogeneic grafts (skin grafts) were transplanted in the 
pregnant uterus, their survival was prolonged compared to that of identical 
grafts transplanted systemically (Beer etal., 1974; Glass etal., 1978).
2). When murine embryonic tissue was implanted elsewhere in the mother's 
body, it was promptly rejected (Streilein etal., 1987).
3). The competence of the immune system of pregnant women was similar to 
that of non-pregnant women. Comparing the phenotype of PBMNG from 
these two groups showed no significant differences (Mincheva-Nilsson etal., 
1992). Maternal antibodies to paternally-derived, fetal-HLA are common in 
the sera of multiparous women (reviewed by Hunt J., 1992a).
4). Numerous studies have demonstrated that a large variety of 
immunocompetent cells infiltrate the murine and human decidua, including 
large granular lymphocytes with natural killer activity, macrophages, and T 
lymphocytes. It has been shown that a subpopulation of these cells from both 
human and mice, or supernatants from their culture, exhibit suppressive 
activity on the immune response (Wood etal., 1988; Ferry etal,, 1990; Parr 
etal., 1990; Golander etal., 1981 ; Nakayama etal., 1985; Matsui etal., 
1989a).
1.1.5. SPONTANEOUS ABORTION
Abortion means the loss of a fetus before It reaches viability. Spontaneous 
abortion is the commonest complication of an established pregnancy. A 
substantial proportion occur without an explanation. A large number of these 
abortions occur in the first trimester of pregnancy; 55% of recurrent abortions 
(three or more successive abortions) were found to occur in this period 
(Llewellyn-Jones, 1990).
The possibility that abortion might be mediated by the abnormality of 
maternal Immunoregulation has attracted considerable attention (Scott etal., 
1987; Clark etal., 1991a). One speculation is that an allogeneic 
incompatibility is necessary at an MHC or a closely linked locus for maternal 
recognition and development of fetal acceptance. If such a recognition is 
lacking, cell-mediated, allograft rejection or antibody response to foreign fetal
antigen may lead to fetal loss (reviewed by Landers etal., 1991). Recently, it 
was found that the percentage of decidual CD3+/HLA-DR+ cells, which are 
characteristic of activated T cells, was significantly higher in spontaneous 
abortions than in normal pregnancies (Maruyama etal., 1992). It suggests 
that abnormal immune regulation in decidua may be involved in this process.
1.2. CELLS AND THEIR INTERACTION IN THE IMMUNE 
RESPONSE
1.2.1. MONOCYTES AND MACROPHAGES
1.2.1.1. Morpholocv and distribution
Monocytes are differentiated from myelomonocytic progenitor cells. After 
maturation, the cells are released from the bone marrow into the peripheral 
blood. They are large cells (12-15 pm) with an large eccentric nucleus 
(occupying more than 50% of the cell space). The cytoplasm contains fine 
and large azurophilic granules, and vacuoles (Auger & Ross, 1992). When 
monocytes migrate to different tissues, they become macrophages. Resident 
macrophages locate in lungs, liver, spleen, bone marrow. Intestine, decidua 
and other areas of the body, and display structural and functional 
heterogeneity. For instance, dentritic cells in peripheral blood and peripheral 
lymphoid organs have an irregular shape and are the most potent 
immunostimulatory cells.
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1.2.1.2. Surface antigens
Monocytes and macrophages interact with their environment by antigens 
expressed on their surface membrane. GDI 4, a receptor that binds 
lipopolysaccharide (LPS), Is characteristic of these cells being expressed at 
high density on both monocytes and tissue macrophages.
These cells also express MHO class II molecules (see Section 1.2.5.1) at a 
high surface density. About 90% of human blood monocytes are HLA-DR 
positive, 32% are DQ positive and 15% DP positive (Asherson & Golizzi, 
1989). In addition, monocytes and macrophages (along with other cell types 
such as B cells and granulocytes) express type I and II receptors for the Fc 
region of IgG (GD64 and GD32 respectively) and type 3 complement 
receptors (GD11 b/GDI 8).
1.2.1.3. Functional characteristics
Macrophages carry out a wide range of functions. These include:
1). Phagocytosis. Various stimuli including foreign material, LPS, antlgen- 
antibody complex and mitogen can stimulate monocytes and macrophages. 
Activated macrophages contain many lysosomes. They phagocytose and kill 
ingested bacteria. They also display tumoricidal activity.
2). Antigen processing and presentation. Exogenous protein antigens are 
phagocytosed by macrophages and degraded into polypeptides. These bind
11
to MHC class II molecules; the peptide-MHO complex on the cell surface can 
be recognised by specific T cell receptors (see Fig. 1.2-1). Thus, as antigen 
presenting cells, they play an important role in initiating and regulating 
immune responses (Benjamini & Leskowitz, 1991).
3). Immunoregulation. Activated macrophages secret prostaglandin (PG) El 
and E2 which mediate the suppression of lymphocytes and NK cells (Pryjma 
etal., 1989). In addition, these cells can secret cytokines such as TNFa, IL-1, 
and TGF8. These cytokines allow mononuclear phagocytes to activate many 
other cells, both immune and non-immune, and play a role in tumor cell 
killing, T cell proliferation and activation.
Functions and surface antigen expression vary according to the state of 
activation and differentiation of the cells, e.g. macrophages can phagocytose 
but unlike monocytes cannot kill the phagocytosed organism unless activated 
by factors such as gamma interferon.
1.2.2. T CELLS
1.2.2.1. Distribution
T cells are derived from lymphoid stem cells In either the bone marrow or 
fetal liver. They migrate to the thymus and further differentiate into antigen- 
specific lymphocytes. The mature cells leave the thymus and enter the blood 
and peripheral lymphoid tissues.
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Mature T cells comprise 65-80% of lymphocytes in peripheral blood. In 
addition, some non-lymphoid tissues also contain a variable proportion of T 
cells, such as the mucosal immune system (including gut, mammary gland, 
female reproductive tract, etc). The sites of graft rejection and autoimmune 
processes also showT cell infiltration (Hunt S., 1987).
1.2.2.2. Surface antigen expression
T cells commonly express the CD3 molecule on their surface which is closely 
associated with the T cell antigen receptor (TcR). TcRs are responsible for 
the recognition and response to specific antigens. The CD3 molecule 
transduces signals from the TcR when it recognises specific antigen. There 
are two kinds of T cell receptors, the a6 receptor which mediates MHC- 
restricted antigen recognition, and the y5 receptor which recognises antigen 
in an non 'classic' MHC-restricted fashion.
T cells express other accessory molecules which are involved in activation 
and interaction with other types of cell. The most important surface antigens 
expressed on T cells are summarised in Table 1.2-1 (adopted from Austyn & 
Wood, 1993).
1.2.2.3. Subsets and their function
T cells are divided into two subpopulations according to the expression of the 
CD4 and CD8 antigens. They represent -70% (CD4+) and -25% (CD8+) of 
the total T cell population in the blood and peripheral lymphoid tissues.
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Table 1.2-1. Surface molecule expression on T cells
(Adopted from Austyn & Wood,1993).
Molecule Function
TcR a8; specific recognition of peptide-MHC complex
TcR X,5; recognition functions
CD2 Interact with LFA-3 (CD58); mediates T cell activation
CD3 Signal transduction from TcR
CD4 Binds MHC class II; mediates cell adhesion (indirectly?)
and signal transduction
CDS T cell activation
CD8 Binds MHC class 1; mediates cell adhesion (indirectly?)
and signal transduction
CD11a/CD18 Binds ICAM-1 (CD54), ICAM-2, others?
mediates cell adhesion
CD28 Binds B7/BB1 ; regulates cytokine gene expression
CD45 A Protein tyrosine phosphatase involved in the
regulation of T cell activation
Thyl T cell activation; cell adhesion
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According to the pattern of cytokines secreted after stimulation, CD4+ T cells 
can be further classified into subsets. Th1 cells secrete interleukin 2 (IL-2), 
interferon gamma (IFNy), tumour necrosis factor (TNFa, TNF3) and 
granulocyte-macrophage colony-stimulating factor (GM-CSF), all of which are 
primarily involved in helping inflammatory-type and cell mediated immune 
responses. Th2 cells produce IL-4, IL-5, IL-6, and lL-10, which are primarily 
involved in antibody-mediated immune responses. Both of them produce IL-3. 
These subsets have been clearly established in mice; the distinction is less 
obvious in humans. Recently, similar subsets have been demonstrated for 
CD8+ cells.
CD4+ T cells are central to the initiation of the immune response. They 
recognise exogenous peptide antigen which has been processed and 
associated with self-MHC class II molecules. In the presence of IL-1, a 
product of activated ARC, the activated CD4+ T cells are able to 'help' the 
immune response by secreting cytokines. Thi cells synthesize IL-2, and IFNy 
which activate CD8+ killer T cells, natural killer (NK) cells, and macrophages. 
Th2 cells produce IL-4 and IL-5 which activate B cells to release the antigen- 
specific immunoglobulins. The interaction of CD80 (B7) on ARC with the 
CD28 receptor on T cells supplies an ‘accessory signal’ for CD4+ cell effector 
function. A diagrammatic representation of the process T cells response is 
illustrated in Fig 1.2-2.
16
Macrophage 
APC (antigen 
processing cell)
helper CD4
virus (immunogen)
class II MHC 
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antigen processing 
IL-1
Tcell 
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for Ag (TCR)
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activation
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cell death )
plasma
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Fig 1.2-2. A diagram of the process of immune ceii response
(modified from Goodman, 1991). See text for explanation.
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CD8+ T cells mediate antigen-specific cytotoxicity. They recognise processed 
endogenous peptide antigens bound to self MHC class I molecule on the 
surface of the target. By releasing the cytotoxic contents of their granules 
they kill the target cells. A proportion of the CD8+ cells can suppress immune 
responses, possibly by the release of soluble factors that interfere with the 
function of other immune cells.
1.2.3. B CELLS
12.3.1. Surface antigens
B cells originate from hemapoietic stem cells in the bone barrow. They further 
differentiate into mature B cells either in the bone marrow itself or in 
peripheral lymphoid organs. B cells comprise 8-15% of peripheral blood 
lymphocytes.
The characteristic marker on mature B cells is the presence of membrane- 
bound immunoglobulin on their surface (sig), which act as the B cell antigen 
receptor. In addition these cells possess receptors for polyclonal B cell 
activators (e.g. LPS), cytokines, and complement (CR1, CD35; CR2, CD21). 
They also express CD22 which is involved in cell adhesion and GDI 9 which 
is invoved in signal transduction. B cells also express MHC class II 
molecules.
1.2.3.2. Functional characteristics
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The major function of B cells is the production of specific antibodies to 
antigens. This function is usually controlled by CD4+ T helper cells. The 
latter cells express a 39 KDa membrane protein that induces T cell - 
dependent B cell activation. The receptor on B cells is CD40 (reviewed by 
Noelle & Snow, 1992). Under the influence of IL-4 and IL-5, the activated B 
cells proliferate and differentiate into plasma cells which secrete antibodies 
(see Fig 1.2-2).
1.2.3.3. Classes of immunoglobulins
Immunoglubulins consist of one or more basic units, each having two heavy 
(H) and two light (L) chains. There are five classes of Ig: IgG, IgM, I g A, IgD 
and IgE, each having structurally different H chains: y, p, a, Ô, and e 
respectively. All of the Igs share two classes of L chains: k  and X. There are 
four subclasses of IgG: IgGI, lgG2, lgG3, lgG4.
Each immunoglobulin molecule has two antigen bind sites (Fab) each made 
up by the combination of the variable region of one heavy and one light 
chain. The biological function of the molecule is associated with the constant 
region of the heavy chains (Fc region).
The molecular weights of IgG, IgM, IgA, IgD and IgE are 150 KDa, 900 KDa,
165 KDa, 180 KDa, and 200 KDa respectively. Mercaptoethanol treatment, 
which reduces the disulfide bonds between the H and L chains shows that
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IgG consists of two 53 KDa H chains and two 22 KDa L chains (Benjamini & 
Leskowitz, 1991).
In some autoimmune diseases, the body produces antibodies against normal 
Ig. For example, rheumatoid factor (an IgM or IgG antibody) binds to the Fc 
portion of normal IgG. These immune complexes are involved in the 
inflammation of joints and the pathologic characteristic of rheumatoid arthritis.
1.2.4. NATURAL KILLER CELLS
1.2.4.1. Moroholocv and distribution
Natural killer cells (NK) are thought to be derived from precursor cells in the 
bone marrow. Most are part of a discrete subset of mononuclear cells - the 
large granular lymphocytes (LGL). These cells are 10-14 pm in diameter, 
have atypical, often kidney-shaped nucleus, and abundant pale staining 
cytoplasm with distinct azurophilic granules. A small portion of NK cells are of 
medium size and agranular.
About 5-10% of peripheral blood lymphocytes are NK cells. These cells are 
also distributed throughout a variety of body tissues, such as the lungs, liver, 
spleen, intestinal mucosa, and peritoneal cavity (reviewed by Lotzova, 1992). 
Recently, a large proportion of LGL were also found in human and murine 
decidual tissue (Starkey, 1992).
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1.2.4.2. Surface antigen expression
The major feature of NK cells is the expression of CD56 (an isoform of neural 
cell adhesion molecule) and receptors for the Fc region of IgG (FcyR), in 
particular the type III receptor - CD16. These cells do not express the T cell 
antigen receptors (a|3, yS) or CD3, or surface immunoglubulin. However, NK 
cells do express some myelomonocytic (e.g. CD11) or T cell (e.g. CD2, CD8, 
IL-2R) markers (Austyn & Wood, 1993).
1.2.4.3. Functional characteristics
NK cells are considered to be part of the innate immune system since they do 
not express classical receptors for specific antigen. NK cells have 
spontaneous, MHC-unrestricted, cytotoxic activity against a number of tumour 
or virally infected cells. This activity may be enhanced by cytokines such as 
IFNy. However, activation of NK cells does not involve secondary or memory 
responses.
Cells expressing GDI 6 exhibit high levels of antibody-dependent cellular 
cytotoxicity (ADOC). However, they do not use this mechanism to kill 
tumours, since NK cell-mediated tumour killing can still occur even when their 
Fc receptors are blocked (Benjamini & Leskowitz , 1991). The exact 
mechanism by which NK cells recognize and kill their targets is still not clear.
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NK cells are involved in allograft rejection, since they can recognize and lyse 
some foreign cell types without prior sensitization. Recently their role in 
reproductive immunology has attracted considerable attention.
NK cells also display immunoregulatory activity through the production of a 
variety of cytokines, including IL-1, IL-2, IL-4, IFNs, and TNFa, 13, etc 
(Lotzova, 1992). Through these cytokines they play a general regulatory role 
in humoral and cellular responses.
1.2.5. ALLOREACTIVITY
1.2.5.1. Major histocompatibilitv complex (MHC)
Products of major histocompatibility complex (or its equivalent) are expressed 
in all vertebrate species. In man they are called the human leukocyte 
associated antigens (HLA). Human MHC class I and class II (HLA) genes are 
located on chromosome 6. There are three independent MHC class I loci (A, 
B, C) each of which codes for a transmembrane polypeptide of molecular 
weight 43 KDa, which is expressed on the surface of cells associated with an 
12 KDa polypeptide, called 32-microglobulin. MHC class I molecules are 
found on every nucleated cell in the body.
The genetic regions coding for MHC class II molecules are DP, DQ, DR.
Each of them codes for a two-chain membrane anchored glycoprotein, the 
chains being called a (34 KDa) and 3 (28 KDa) respectively. Unlike MHC
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class I molecules, class II molecules have a limited cellular distribution. They 
are found on immunocompetent cells such as B lymphocytes, macrophages, 
dendritic cells, thymic epithelial cells and activated human T cells.
One of the important characteristics of MHC molecules is their polymorphism. 
Within each locus, a large number of variants exists in the population as a 
whole. As a result, different individuals express different MHC molecules on 
their cell surface (Benjamini & Leskowiyz 1991).
In addition to MHC antigens, minor histocompatibility antigens, encoded by 
minor histocompatibility genes on different chromosomes, may be 
immunogenic in different individuals (Austyn & Wood, 1993).
1.2.5.2. Alloreactivitv
An allograft is a transplant from one individual to a genetically dissimilar 
individual of the same species. A large proportion of T cells from any 
individual can recognize and respond to the foreign MHC molecules. This 
reactivity against allogeneic MHC molecules is called alloreactivity (Austyn & 
Wood 1993).
The T cells that recognize foreign MHC molecules expressed on grafted cells 
are known as alloreactive T cells. Among them, CD4+ T cells recognize 
foreign class II molecules (which resemble foreign Ag associated with self 
MHC class II molecules) and CD8+ T cells recognize class I molecules
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1.2.5.3. Immunological tolerance
Immunological tolerance refers a state of the Immune system that is 
manifested by a diminished or absent capacity to express either cell- 
mediated or humoral immunity. Normally, the bodyis immune system does 
not respond to self-antigens. The main theories to explain this phenomenon 
are clonal selection and clonal anergy (i.e. APC fail to deliver co-stimulatory 
signals making the specific T cell unable to respond to the antigen). 
Suppressor T cells may also play a role in T-cell tolerance. In in vitro 
experiments, immunological tolerance of adult T and B cells to foreign 
antigens have been induced by the use of relatively large doses or small 
doses of antigens, given repeatedly over long periods of time. The weaker 
the immunogenicity of an antigen, the easier to induce tolerance to it in mice 
(Benjamini & Leskowiyz 1991).
Maternal mmunological tolerance to the fetus may be due to inefficient 
antigenic stimulus due to the regulation of the expression of MHC antigens 
on trophoblast, or due to the immunosuppression resulting from the various 
suppressive factors derived from fetal-maternal interface (see 1.1.4).
(which resemble foreign Ag associated with self MHC class I molecules).
APC in grafts secrete IL-1 which aids in triggering lymphocyte activation. 
Once CD4+ T cells are activated, they release IL-2 which activates CD8+ T 
cells and B cells. As a result, the effector cells can directly destroy graft cells 
by cytotoxic T cell mechanisms (see Table 1.2-2). An in vitro assay, the mixed 
lymphocyte culture reaction (MLR), is used to assess the extent of this 
allogeneic reaction.
1.2.6. POTENTIALLY IMMUNOCOMPETENT CELLS IN THE DECIDUA
tKe
There are three major types of cells found injirst trimester human decidua: 
stromal cells, glandular epithelium, and leukocytes. They are interspersed 
with stromal fibroblasts and blood vessels (Parhar,1988). The leukocytes 
(including lymphocytes, macrophages and neutrophils) are present either in 
aggregates situated adjacent to the glandular epithelium, or scattered 
amongst other cells (Mincheva-Nilsson,1992). After disruption of decidual 
tissue by enzymatic or mechanical methods, a higher proportion of potentially 
immunocompetent cells are obtained in the mononuclear cell layer. 
Phenotypic and functional analyses of these cells have provided some 
information about their composition.
1.2.6.1. Large granular Ivmphocvtes (LGLL
A large proportion of decidual mononuclear cells (DMNC) are LGL. They 
comprise between 40% to 70% of DMNC population (Mincheva-Nilsson etaL,
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1992; Ferry etaL, 1990; King etaL, 1991). The main characteristic of these 
cells is that they express a natural killer (NK) cell marker, CD56. Although 
the majority of CD56+ cells express the early T-lineage markers, CD2 and 
CD7, they do not express the mature T-cell antigens such as CDS, CDS and 
CD4/8, They also express CD11a/CD18 (integrins) and CD38. Unlike 
peripheral blood NK cells, only a few decidua LGL express GDI 6. Decidua 
LGL have low NK activity against the K562 cell line compared with their 
peripheral blood CD56+ counterparts (Reviewed by King et al, 1991). These 
cells express only the p75 chain of the IL-2 receptor (IL-2RB), and have a low 
proliferative capacity in response to IL-2 (Christmas et al, 1990).
1.2.6.2. Macrophages.
Macrophages have been shown to constitute a variable but significant 
proportion of human decidual cells. Estimates vary from 14% to 20%
(Bulmer, 1989; Loke ef a/, 1991; Mincheva-Nilsson etal, 1992). These cells 
express GDI4, and the majority of them express the class II MHC gene 
products, HLA-DR, or DP, DQ (Lessin etal., 1988; Bulmer, 1989). It was 
reported that these cells can suppress lymphocyte alloreactivity in vitro 
through the release of prostaglandin E2 (Parhar etal., 1988).
1.2.6.3. T Ivmphocytes.
Mature decidual T lymphocytes comprise a population of between 10% to 
23% of DMNC (Loke eta!., 1991; Mincheva-Nilsson etal., 1992). They are 
CD3 positive cells. The majority of them areo f^ T cells, and express CD4 or 
CD8. Both CD4+ and CD8+ subsets express significantly higher CD69, HLA- 
DR, IL-2Ra and IL-2R3 antigens than their peripheral blood counterparts, 
indicating they have been activated (Saito etal, 1992). A proportion of ja  T 
cells has been found in murine decidua; they seem to be able to recognise 
trophoblast in an MHC-non-restricted fashion (Heyborne etal., 1992, 1994). 
B cells and polymorph cells are very rare in decidua tissue.
1.2.6.4. Non-leukocvte decidual cells.
Some non-Ieukocytic cells found in the decidua have been shown to have 
immunomodulatory activity. Decidual stromal cells, for example, were 
reported to be inhibitory in mixed lymphocyte culture reaction and in the 
generation of cytotoxic T cells (Parhar etal., 1988). In murine decidua, it has 
been shown that decidual stromal cells inhibit several macrophage functions 
(Redline et al., 1990).
As mentioned above, these Immonocompetent cells have potentially 
immunomodulatory activity (Summarised in Table 1.2-2). However, their 
immunoregulatory mechanisms during normal pregnancy are still far from 
clear. Severe combined immunodeficient (SCID, deficient in NK cell and 
lacking T cells and B cells), and beige mutant (depletion of NK cell function) 
mice were found to reproduce normally. It has been suggested that the 
inhibitory cytokine derived from decidua may not be from classical mature 
NK cells, T cells, or B cells (Croy et al, 1990).
1.3. IMMUNOREGULATORY FACTORS
1.3.1. CYTOKINES
Cytokines are a group of soluble, polypeptides or glycoproteins with 
molecular weights (M.w) of < 30 KDa. They are induced by specific stimuli 
and regulate the function of effector cells. Cytokines produced by 
lymphocytes are called lymphokines; cytokines produced by monocytes or 
macrophages are called monokines. Cells of the immune system can interact 
with each other via cytokines. They can act on cells other than those which 
produced them (paracrine activity) or on the cells by which they were 
secreted (autocrine activity).
1.3.1.1. Immunostimulatorv cvtokines
A variety of cytokines have the capacity to stimulate the immune response. 
This information is summarised in Table 1.3-1.
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Among these stimulatory cytokines, IL-2 plays a central role in the immune 
response. It is secreted by CD4+ Th1 cells (and others), and exerts 
numerous immunological effects by stimulating cellular proliferation and the 
production of other cytokines by T cells, B cells, and NK cells. The biological 
effects of IL-2 are mediated through the binding of the growth factor to 
specific receptors present on cell targets. There are three forms of the IL-2 
receptor: one is low affinity (IL-2Ra); the second is of intermediate affinity (IL- 
2Rp); and the third is a heterodimetric complex of the previous two with high- 
affinity for IL-2 (Kuziel & Greene, 1991).
1.3.1.2. Immunosuppressive cvtokines
Cytokines with immunosuppressive activity include transforming growth factor 
P (see Section 1.3.2) and IL-10. The former is closely associated with this 
study, and is emphasised in Section 1.3.2.
IL-10 was initially discovered as an inhibitor of cytokine synthesis (TNF, IL-1 
and IL-6) and was called cytokine synthesis inhibitory factor. Under different 
conditions of immune activation, CD4+ T cells, as well as monocytes, 
macrophages and B cells are capable of secreting it. IL-10 is an acid- 
sensitive (pH < 5.5) protein which Is stable in basic conditions (pH up to 11) 
with a M.w. of 30-40 KDa. It has been reported to be exhibit a wide range of
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Table 1.2-2. Immunoregulatory cells in human decidua.
Cell Type Proposed Function
Large granular lymphocytes 
Macrophages
T lymphocytes
Non-Leukocytic cells
NK activity
Immunosuppression
Antigen presentation
Immunorecognition
Immunosuppression
Immunosuppression
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Table 1.3.1. Characteristic properties of immunostlmulatory cytokines
(modified from Oppenheim, 1991 & Roitt, 1991)
Cytokine M.w
(KDa)
Principle Cell 
Sources
Stimulator
Function
IL-1 17.5 Macrophages & others Immunoaugmentation.
IL-2 15.5 T cells & LGL T & B cell growth factor; 
Activates T & NK cells.
IL-4 20 CD4+ T cells I  & B cell growth factor.
IL-5 18 CD4+1 cells Stimulates B cells; 
Production of Ig.
IL-6 22-30 CD4 T cells 
fibroblasts & others
Growth factor for B cell; 
Polyclonal immunoglobulin 
production.
IFNa 18-20 Leukocytes Antiviral;
IFNp 25 Fibroblasts Expression MHC 1.
IFNy 20-25 T cells Stimulates macrophages 
& NK cells;
Induce cell membrane 
antigens (eg, MHC)
TNFa 17 Macrophages & others Immunoenhancing &
TNFp 18 I  lymphocytes Tumoricidal
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immunosuppressive activity including inhibition of cytokine production and 
the killing of intracellular pathogen by macrophages, suppression of MHC 
class II expression on macrophages, and due to its action on macrophages 
and other APC, inhibition of the proliferation and /or cytokine production by T 
cells, Thi clones and NK cells (reviewed by Howard et al., 1992 a, b & 
Rennick etal., 1993).
1.3.2. TRANSFORMING GROWTH FACTOR p (TGFp)
Originally, TGFp was defined as a cytokine which was able to induce certain 
non-neoplastic cells to express a transformed phenotype and to undergo 
anchorage-independent growth (Roberts etal., 1983). So far, five members of 
it have been identified in mice: TGF p i, p2, p3, p4 and ps. The first three 
types have also been identified in human cells and show a high degree of 
homology at the level of amino-acid sequence. For example, TGFP2 shares 
71% homology with pi ; TGFp3 shares 72% with pi and 76% with p2. The 
most studied molecules in this family Is TGFpl. In most instances, the effect 
of the various TGFp isoforms are indistinguishable. One notable exception is 
the relative lack of inhibitory effect of TGFp2 on growth of endothelial cells 
(Robert & Sporn, 1992).
1.3.2.1. svnthesis of TGFp
TGFp is produced by a variety of tissue and cell types, such as human 
placenta, platelets, activated macrophages and lymphocytes (Frolik etal.,
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1983; Assoian, 1983; Kehrl, 1986; Kehr!, 1987; Assoian 1987). TGFp is 
released in a latent form (391 amino acids) and is subsequently activated by 
some physiological factors which may result in alteration of the glycosylation 
of the amino-terminal glycopeptide (Lyons etal., 1990). In vitro, activation of 
latent TGFp is commonly achieved by acidification of cell-conditioned 
medium (Lyons etal., 1990).The purified TGFp with biological activity is a 
polypeptide of 25 KDa (112 amino acids) which is composed of two 12.5 KDa 
subunits held together by disulfide bonds. It has been demonstrated that the 
dimeric nature of this molecule is very important; the disruption of the 
structure resulting in a total loss of biological activity (Assoian etal., 1983).
1.3.2.2. Biological activitv
TGFp is involved in many cell and tissue functions. So far, the range of its 
known biological activity has extended to nearly all types of cell. It exhibits 
multiple modulating functions on these cells. It stimulates some cell types, 
and inhibits the proliferation and function of others. It is involved in tumour 
development, extracellular matrix protein synthesis, wound healing, 
embryogenesis, and bone formation / fracture healing. In the immune system 
it enhances the functions of monocytes, i.e. migration and the respiratory 
burst. However, it may affect the growth of all lymphocytic cells as 
demonstrated by its ability to inhibit IL-1 dependent thymocyte proliferation in 
the presence of a suboptimal concentration of phytohemagglutinin (Wahl et 
al., 1988); the IL-2 dependent proliferation of Con A-stimulated T cells (Kehrl 
etal., 1987); IL-2 dependent B cell proliferation, and Ig secretion by B cells
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(Kehrl etaL, 1986); allospecific cytotoxic T cell development (Ranges etaL, 
1987); NK cell activity and the cytotoxic activity of peripheral blood LGLs 
(Rook etaL, 1986).
1.3.2.3. Mechanism of action
In spite of their similarity in biological activity, TGFpl and p2 have different 
receptors on their target cells. Briefly, they share a 280 KDa receptor; but 
only p i , not p2, interacts specifically with a 65 KDa and an 85 KDa receptor 
(Cheifetz etaL, 1987). The intracellular signalling pathway, after the 
occupancy of these receptors, is not clear yet. Although GTP-binding protein 
has been shown to be involved in the process, no evidence of intracellular 
Ca++ fluxes, inositol phosphate, or kinase activity has been found (Lyons et 
al., 1990). It has been shown that blockage of DNA synthesis in target cells 
by TGFp is due to its arresting the cells in the middle to late G1 phase, 
delaying enter into S phase. This inhibition is reversible and thus not the 
result of cytotoxicity (Shipley etaL, 1986).
1.3.3. PROSTAGLANDIN
1.3.3.1. Svnthesis and classification
Prostaglandins (PGs) are a family of lipid-soluble molecules. The major 
precursor of PG is arachidonic acid, which is derived from the metabolism of 
membrane phospholipids by the action of the enzymes phospholipase A2 and 
C. Arachidonic acid has a short half-life and can be metabolised by two major
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routes, the cyclo-oxygenase and lipoxygenase pathways. The products of the 
former are PGs; the latter are leukotrienes mainly involved in inflammatory 
process (reviewed by Pruzanski etaL, 1991). Fig 1.3-1 illustrates this 
metabolic process.
So far, at least 16 different prostaglandins have been identified. According to 
the difference in their chemical substituents they can be divided into nine 
different classes, designated PGA to PGI.
1.3.3.2. Reculation of PG production
PGs are found in many human tissues. Almost all mammalian cells, except 
red blood cells, produce PGs and their related compounds. Different cell 
types produce different PGs. For example, heart muscle makes PGI2,
PGF2a, and PGE2, monocytes and macrophages synthesise PGE2 and 
PGF2, mast cells produce PGD2, and lymphocytes may produce PGE2 but 
this is controversial.
PGs do not exist free in tissues, but have to be synthesized and released in 
response to an appropriate stimulus. For example, PGE2 can be induced by 
IL-1, TNFa, the cross-linking of Fc receptors, llpopolysaccharide (LPS) and 
components of the complement cascade. These molecules have a short half- 
life and act in the same environment in which they are synthesized (Phipps et 
al, 1991 ; Austyn et al, 1993).
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Fig 1.3-1. The diagram of the synthesis of prostagiandins
(Modified from Austyn etal, 1993).
Phosphoiipids in 
Cell Membranes
WArachidonic acid
Phospholipase A2 and 0
Cyclo-oxygenase
Prostanglandins
Lipoxygenase
Leukotrienes
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Some nonsteroidal anti-inflammatory drugs, such as aspirin and 
indomethacin can inhibit the synthesis of the prostaglandins by inhibiting or 
inactivating cyclooxygenase activity (Voet etaL, 1990). Therefore, these 
inhibitors have been used to elucidate the biosynthesis of PGs, and their 
functions.
1.3.3.3. Bioioaical activitv
The biological activity of PGs is incredibly diverse. They are intimately 
involved in the inflammatory response, regulate blood pressure, control 
several reproductive functions such as the induction of labor, induce blood 
clotting, and regulate sleep/wake cycle (Voet etal., 1990). The 
immunoregulatory effect of PGs has been extensively studied.
In general, PGEs are non-specific suppressors of the immune response. 
They inhibit a variety of lymphocyte functions including proliferation, IL-2 and 
other interleukin production, the synthesis of Ab by B ceils, CTL and NK 
cytotoxicity, leukocyte locomotion and cell and cell interactions (Austyn etal., 
1993; Phipps etal., 1991)
Recently, it has been shown that PGEs may enhance the synthesis of certain 
isotypes of immunoglubuiin and selected cytokines and cytokine receptors 
(reviewed by Phipps etal., 1991).
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1.3.4. CYTOKINES AND OTHER IMMUNOREGULATORY FACTORS 
DERIVED FROM DECIDUA
1.3.4.1. Cvtokines
A variety of cytokines have been found in human or murine decidua and 
placenta (Table 1.3-2).
1.3.4.2. TGFp
There have been several reports about the generation of TGFp-like
molecules and their immunosuppressive activity from murine decidua (Clark
etal., 1988,1990). This molecule inhibits allospecific CTL responses by the
inhibition of the action of IL-2 on CTL development, and lymphokine-activated
killer cell generation. The supernatant of decidual cell cultures also
(normal rat kidney) 
stimulates anchorage-independent growth of the NRK cell, which is defined
as a function of TGFp (Clark etal., 1985). In addition, TGFp-like molecules
have been detected at high concentration in amniotic fluid (Altman etal.,
1990). The effects of the factors in both decidual supernatants and in
amniotic fluid could be neutralized by anti-TGFp2, but not p i, monoclonal
antibodies (Altman etal., 1990; Lea etal., 1992).
1.3.4.3. TUMOR NECRfBIS FACTOR a (TNFa^
TNF was originally identified as a product of activated macrophages (TNFa) 
and lymphocytes (TNFp) that caused a wasting syndrome in tumour-bearing 
animals, regression of some tumors, and hemorrhagic necrosis in certain
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Table 1.3.2. Production of cytokines by uterine and decidual cells.
(adopted from Robertson et al., 1994)
Cytokine Uterus/decidua Placenta
CSF-1 Yes (H,R)* Yes (H), No
GM-CSF Yes (H,R) Yes (H,R)
IL-3 Yes/No (R) No (R)
G-CSF Yes (H) Yes (H)
iL-1 Yes (H,R) Yes (H,R)
IL-2 Yes (R) Yes (H,R)
IL-4 Yes (R) Yes (H,R)
IL-5 Yes (R) Yes (H), No (R)
IL-6 Yes (H,R) Yes (H,R)
IFNa Yes (H,R) Yes (H,R)
IFNy Yes (H,R) Yes (H,R)
TNFa Yes (H,R) Yes (H,R)
TGFp Yes (H,R) Yes (H,R)
H=human; R= rodent
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tumor tissues. TNF could stimulate T and B lymphocyte function and 
proliferation. In conjunction with IFNy, it could up-regulate MHC antigen 
expression in several cell types.
Several groups have demonstrated biological activity of TNFa in human 
decidua (Jaattela etal., 1988; Casey etal., 1989; Chen etal., 1991 ; Vince et 
al., 1992). It appears that quite a few ceii types are capable of producing this 
factor, i.e. decidual stromal cells, and macrophages. It has been proposed 
that TNFa may cause the immunosuppression seen in human decidua (Hunt, 
1992b). However, since TNFa is usually recognised as an 
immunopotentiating agent which stimulates the proliferation of lymphocytes 
and enhances the functional response of lymphocytes and macrophages, it 
has been argued that its increased production in pregnancy may threaten 
fetai survival (Vince etal., 1992; Clark etal., 1991b).
1.3.4.4. Prostaglandins
Prostagiandins also have been demonstrated in early murine decidua 
(Matthews & Searle, 1987). In human decidua, PGE2 was identified as a 
primary source of suppression (Parhar etal., 1988). Addition of 
indomethacin, an inhibitor of prostanglandin synthesis, eliminated the 
suppression (Wood etal., 1988).
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1.3.4.5. Human decidua-associated protein hPP 200 fhDP2QQ^
Human decidua-associated protein hDP 200 was identified in 1990 
(Halperin etal)  and named according to its molecular weight in non­
reducing SDS-PAGE analysis (hDP200). SDS-PAGE analysis performed 
under reducing conditions showed that hDP200 is composed of two 
polypeptide chains of M.w of 55 and 25 KDa. From amino-terminal sequence 
analysis, hDP200 seems to be an immunoglubuiin G-like molecule (Halperin 
etal, 1994). It has not known if this molecule has any immunoregulatory 
function. Another group has reported that human decidua extracts inhibited T 
cell -mitogen induced proliferation of PBMNG, and the causative factor (M.w 
158 KDa) was IgG or a substance copurified with IgG as demonstrated by 
Immunoelectrophoresis and double immunodiffusion (Kitano etal., 1990). 
The latter one may be identical with hDP200.
1.4. AIMS OF THIS STUDY
The mechanisms involved in the protection of the fetus from attack by the 
maternal immune response have not been elucidated clearly. Especially the 
factors responsible for maintenance of the fetus during early pregnancy in 
humans are poorly understood. An understanding of these mechanisms may 
provide an insight into the maintenance of tolerance to foreign antigens and 
thus the pathology of many immunological diseases. This would also have 
implicationsfor the survival of therapeutic tissue and organ transplants.
The present study was designed to investigate potential immunosuppressive 
factors from^first trimester human decidua using a variety of biochemical and 
Immuniogicai techniques. These factors were to be identified and 
characterised, an attempt was to be made to identify the cells which produce 
them in the human decidua.
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CHAPTER 2
MATERIALS AND METHODS
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2.1. PREPARATION OF DECIDUAL FRACTIONS
2.1.1. COLLECTION OF DECIDUAL SAMPLES
First trimester human decidua were obtained from women undergoing 
therapeutic abortion of healthy pregnancies. Gestational age was calculated 
from the date of the last menstrual period. All operations were carried out 
under sterile conditions. Maternal decidual tissue was separated from fetal 
tissue by the surgeon at the time of operation, and samples for the 
preparation of soluble decidual extracts were frozen at -20 °C immediately 
and transferred to -70 °C as quickly as possible. Samples to be used for the 
isolation of decidual mononuclear cells were transported to the laboratory in 
less than 3 hours and were processed immediately.
2.1.2. ULTRAFILTRATION OF SOLUBLE DECIDUAL EXTRACTS
2.1.2.1. Preparation of extracts.
Samples were defrosted in a waterbath (37 °C) and when nearly thawed, a 
portion was diluted 1:8 (v/v) with pre-cooled PBS (4 °C) and homogenised 
(Poiytron homogenizer, speed No. 6). An aliquot of the lysate (50 pi) was 
stained with 0.2% trypan blue to assess the extent of cell disruption.
Residual cells and cellular organelles were removed by transferring the 
homogenate to 250 ml tubes and centrifuging (26,000 g; 4 °C) for 35 minutes
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using a Beckman centrifuge (Model JA-21 equipped with rotor model JA-14). 
Some small fat droplets visible on the surface of the supernatant were 
removed carefully using a Pasteur pipette. The clarified supernatant was 
collected for subsequent separation.
2.1.2.2. Uitrafiitration of the extract
A Minitan ultrafiltration system (Mlllipore) was employed to concentrate and 
crudely fractionate the decidual extract. Four different types of Minitan normal 
molecular weight cut-off membranes (NMWC) were used with the nominal 
exclusion level of >10, >30, >100 and >300 KDa (Mlllipore, type PTGC,
PTTK, PTHK, and PTMK). The decidual supernatant was initially filtered 
through two 10 KDa filters, generating <10 KDa fraction. The retentate was 
collected and filtered through two 30 KDa membranes, producing a fraction 
with approximate molecular weight range of 10-30 KDa. In a similar manner, 
30-100 KDa, 100-300 KDa and >300 KDa fractions were collected by using 
the membranes described above. After ultrafiltration, the individual fractions 
of <10,10-30, 30-100,100-300, and >300 KDa were pooled, sterilised using 
a 0.2 pm filter (Millpore), and a portion stored at -70 °C for further purification. 
Smaller aliquots were also stored at -70 °C until assayed for their 
immunoregulatory activity.
2.1.3. FURTHER PURIFICATION OF DECIDUAL EXTRACTS.
2.1.3.1. Preparation of sample
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Crude decidual protein fractions (CDPF) with M.W. 10-30 KDa and 30-100 
KDa, which were found to have immunoregulatory activity in preliminary 
experiments, were mixed and loaded into a 10 KDa macrosep centrifugal 
concentrator (Filtron, Northborough, MA, USA). After centrifugation (3600 g; 
50 min; 4 °C), the concentrate was collected and the process repeated. The 
protein concentration of the concentrated extract was approximately 
3-4mg/ml as assessed by the Ohnishi and Barr (1978) modification of the 
method described by Lowry (1951).
2.1.3.2. Fast performance liquid chromatoaraohv (FPLCl 
Gel filtration chromatography was performed using a XK 2.6/70 column 
(Pharmacia, Sweden) packed with pre-swollen Sephacryl S-100 HR (Sigma; 
fractionation range: 1-100 KDa). The column was connected to a FPLC 
system (Pharmacia). Depending on the separation requirements, either PBS 
(pH 7.1), or 0.1 M acetic acid and 0.1 M KOI (pH 2.9) was used as eluent 
buffer. The column was pre-equilibrated with appropriate eluent buffers 
before application of the sample (3.5 ml). The column was run at 0.75 mi/min 
(8.5ml /cm^ /h) and the eluate (2.6 ml under neutral conditions, or 3 ml under 
acid conditions) collected automatically. Where appropriate, fractions were 
pooled, sterilised using a 0.2 \im filter (Millpore), aliquoted in Eppendorf 
tubes and stored at -70 °C.
In order to estimate the molecular weight of the decidual extracts, the column 
was calibrated using protein M.w standards (Sigma) under neutral conditions.
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To estimate the protein concentration of FPLC fractions, a standard curve 
was obtained using bovine serum albumin solution of known concentration 
and a Multiskan MOO Spectrophotometer with a 280 nm test wavelength 
filter.
2.2, BIOCHEMICAL ANALYSIS OF DECIDUAL EXTRACTS
2.2.1. SODIUM DODECYL SULPHATE - POLYACRYLAMIDE GEL 
ELECTROPHORESIS (SDS-PAGE)
Decidual extracted proteins were resolved using the Laemmii 
SDS-discontinuous buffer system (1970). The composition of the stacking gel 
and resolving gels and all buffers used are given in Appendix.
Glass plates were washed with detergent, and rinsed in turn with MiliiQ 
water, ethanol, and acetone before assembly in the gel holders. The 
resolving gei (either 12% or 7.5% depending on the samples) was poured 
between the glass plates, care being taken to prevent trapping air bubbles. 
The surface of gel was overlayed with 200 j l i I  of water-saturated butanol toA
prevent oxygen-dependent inhibition of polymerization, and to ensure a 
smooth surface. The gel was allowed to set for 30-40 min at room 
temperature.
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The overlay was poured off and the surface of the gel rinsed three times with
resolving buffer to remove residual butanol. A 5% stacking gel was poured
over the resolving gel. Its height was twice that of the samples to be applied,
and the sample well comb inserted. Once the gel was set (30-40 min; room
temperature), it was placed in the electrophoresis tank and the comb gently
removed. The surface of the gel was washed with tank buffer. The samples
then cooled
(in sample buffer) were heated for 5 min in a boiling waterbathy^^nd carefully 
loaded into the appropriate sampie wells. Prestained M.w. markers (Bio-Rad) 
were included to calibrate the gels.
The proteins were electrophoresed in tank buffer at 150 V until the dye had 
passed the stacking gel where upon the voltage was raised to 200 V for the 
resolution of the proteins. The process was terminated when the buffer dye 
arrived at the bottom of the resolving gel.
2.2.1.1. Detection of proteins
In order to visualise the resolved protein, SDS-PAGE gels were incubated 
with Coomassie brilliant blue at room temperature for 1 hour, the process was 
enhanced by gentle rocking. Excess stain was removed by incubation with 
fix/destain until the desired reduction in background was achieved. The 
composition of the stain and destain used are given in Appendix.
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2.2.1.2. Density measurement of protein bands
To quantify the amount of protein in each band on the gels, the absorbance 
of the peak area of each band was measured using a densitometer 
(Shimadzu, Japan) and analysed with an on line computer. The results were 
expressed as arbitrary units.
2.2.2. WESTERN BLOTTING
2.2.2.1. Protein transfer
The mini western blot was transferred on to a Hybond-C super nitrocellular 
membrane (Amersham) using a semi-dry blotter. The gel / membrane were 
sandwiched between sheets of blotting paper which had been soaked in 
transfer buffer for 20 min prior to transfer. Electrophoresis was at 10V for 24 
min. When electrotransfer was done, the membrane was stained immediately 
or dried and stored at 4 °C for later use.
A trans-blot cell was used to transfer the proteins from standard sized gels. 
The trans-unit was assembled as follows: filter pad, 3 mm paper, hybond-C 
super nitrocellulose membrane, protein gel, 3 mm paper, and filter paper. The 
unit was placed into the Trans-blot cell which was already full of transfer 
buffer. The membrane was toward to positive electrode. The electrophoresis 
was 60V for 3 hours or 25V overnight at 4 °C.
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2.2.2.2. I m mu nostain
The immunodetection of TGFp-like factors from relevant decidual fractions 
was performed using an enhanced chemiluminescence (EGL) procedure 
(Amersham). Horseradish peroxidase (HRP)-linked secondary antibody, in 
the presence of hydrogen peroxidase (H2O2), catalyses the oxidation of 
luminol. During this process the luminol is in an excited state which may 
decay to ground state via a light emitting pathway.
The Western blot was rinsed with MilliQ water to remove any transfer buffer,
immersed in blocking buffer and soaked slowly for 1 hour to block
non-specific binding sites. The blot was incubated with primary antibody on a
roller incubator at room temperature for 2 hours. At the end of the incubation
period, the primary antibody solution was decanted. Unbound antibody was
washed by briefly rinsing the membrane in a large quantity of MilliQ water,
and 3x10 min shaking in TTBS. The blot was then incubated with secondary
Ab-HRP or biotinylated secondary antibody for 1 hour on a roller incubator. In
the case of the latter, the blot was washed as described above, and then
incubated with Extravidin (HRP-conjugated) for 1 h. At the end of the
incubation time, it was washed as described above. The plot was exposed
using a mixture of equal volumes of EGL reagents 1 and 2 for 1 min and then
wrapped in Saran-wrap and exposed to X-ray film for 1 min to 1 hour 
(see Appendix 7.4).
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2.2.3. RADIAL IMMUNODIFFUSION
In order to ascertain whether any of the decidual fractions contained 
immunoglobulin, radial immunodiffusion was carried out using an 
Ouchterlony double diffusion test (Hudson eta!., 1989). Noble agar (1.5% in 
0.3 M phosphate buffer) was prepared in a glass tube, and boiled in a 
waterbath until the agar solution was clear. The tube was removed and 
allowed to cool to about 56 °C, when it was poured into petri dishes (15 ml / 
dish). The agar was allowed to set under sterile conditions and the dishes 
stored in a moist box at 4 °C until use.
Wells were punched in the gel using a stainless steel cutter (diameter 3 mm; 
well separation, 7.5 mm centre to centre) and a syringe needle was used to 
pierce the agar plug and lift It clear. Decidual fractions, and appropriate 
antibodies at various concentrations (5 pi of each) were carefully loaded into 
the wells. The dishes were stored in a moist box at 4 °C for 24 h. The 
immunoprécipitation lines were examined and photographed.
2.3. FUNCTIONAL ANALYSIS OF DECIDUAL EXTRACTS
2.3.1. CHARACTERISATION OF TRANSFORMED HUMAN CELLS
2.3.1.1. Human cell lines
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Mono Mac 6 cells were purchased from the German collection of micro­
organism and cell cultures, Braunschweig, Germany. The cells were 
originally derived from a patient with myeloid metaplasia (Ziegler-Heitbrook et 
ai, 1988).
THP1, U937 and Jurkat E6.1 cells were obtained from the European 
Collection of Animal Cell Culture (Porton Down, Wiltshire). THP1, a human 
monocytic cell line (ECACC No. 88081201) was originally derived from the 
peripheral blood of a patient with acute monocytic leukaemia (Tsuchiya etaL,
1980). U937, as human histocytic lymphoma (ECACC No. 85011440) 
originated from the pleural fluid of a patient with diffuse lymphoma 
(Sundstrom etaL, 1976). Jurkat E6-1 cells (ECACC No. 88042803) are a 
leukaemic T lymphoblastoid cell line.
All cell lines were adjusted to 2-5x10 ® cells /ml in complete medium (RPMIc).
To maintain them in an exponential growth phase, the cells were subcultured 
at 3-4 day intervals using fresh RPMIc to dilute the cells.
For storing, cells were pelleted (400 g, 10 mins) and resuspended at 5-10 
xIO®/ml in either 10% glycerol (BDH; THP1 and Jurkat E6.1 cells) or 10%
DMSO (Si g mal Chemical Ltd) in RPMIc. The cell suspension was transferred 
to cryo-tubes (Nunc; 1ml /vial), and frozen overnight at -70°C freezer. The following 
day the cells were transferred to liquid nitrogen.
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To recover cells from liquid nitrogen, they were thawed rapidly in a 37 “C 
water bath and the cell suspension slowly transferred to a centrifuge tube 
containing 10 ml of RPMIc using a sterile plastic Pasteur pipette. After 
washing (360 g, 3 min), the cells were resuspended in 10 ml of RPMIc and 
incubated at 37 °C (5% CO2) in an humidified incubator.
2.3.1.2. Cell proliferation and cvclinc
Propidium iodide (PI) is a dye which binds specifically to nucleic acids by 
intercalating between the bases in double-stranded DNA and RNA. After 
being stained with PI, the dye may be excited by UV or blue light to emit red 
fluorescence. By using ribonuclease (RNase) to cleave RNA, PI can be used 
for,yisualisation of the cell cycle (Ormerod, 1994).
As PI is unable to pass through an intact cell membrane, it was used for 
assessing cell viability and to exclude the influence of dead cells on cell cycle 
analysis. For this purpose, PI was directly added to the cell suspension 
without previous fixing.
To assess cell cycle distribution, 10 ® cells were transferred to a FACScan 
tube. After washing (400 g; 5min; PBS), the cell pellets were resuspended in 
200 pi PBS. Subsequently, 2 ml of ice cold, 70% ethanol in PBS was added 
and the samples left at 4° C for 30 min. After washing (400 g; 5 min; PBS), 
the cells were resuspended in 800 pi of PBS, 100 pi RNase (30 p/mi in PBS; 
Boehringer, Mannheim GMbH), and 100 pi PI ( 400 pg/ml in PBS; Sigma
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Chemical Ltd.). After incubation at 37°C for 30 min, the samples were 
analysed using the FACScan and FACScan research software.
To assess cell viability, PI was added to an unfixed sample of the cell 
population, and analysed as described above.
2.3.1.3. Phenotvpic analvsis
Cells which were to be phenotypically characterised were treated as 
described below. An aliquot of cells (0.5-1 xIO® cells) in PBS was transferred 
to a FACScan tube (Becton Dickinson). After washing in PBS (400 g; 5 mins), 
the cell pellets were resuspended in PBS, and saturating volumes of the 
appropriate MoAb (10-20 pi; according to the manufacturers' instruction) were 
added. The samples were mixed well and kept on ice for 30 min. Thereafter 
they were washed twice with ice-cold PBS, resuspended in 1 ml cold PBS 
and placed on ice until analysed using the FACScan flow cytometer (Becton 
Dickinson, USA) equipped with an argon ion laser (488 nm, 15mV) and 
FACScan research software. Appropriate isotype controls were included in 
each experiment.
2.3.2. MITOGEN INDUCED LYMPHOCYTE PROLIFERATION
2.3.2.I. Isolation of peripheral blood mononuclear cells (PBMNC)
Samples of heparinized venous blood (10 p/ml) were obtained with informed 
consent from healthy volunteers. The blood was diluted with an equal volume
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of RPMI at room temperature and layered over 12 ml of lymphoprep 
(Nycomed, Birmingham, UK). After centrifugation (400 g; 30 minutes), the 
interface cells were harvested. After washing twice with RPMI (400 g; 10 
minutes), the cell pellets were resuspended in RPMIc and counted using an 
Improved Neubauer haemocytometer and trypan blue exclusion (0.2% v/v in PBS) 
as a measure of viability. Cells were diluted to the required concentration with 
RPMIc.
2.3.2.2. Mitooen-induced Ivmphocvte proliferation
In this assay, 100 or 200 pi aliquots of freshly isolated PBMNC in RPMIc 
(10®/ml) were placed in each well of a 96-well tissue culture plate. To each 
well was added either 10 pi RPMIc (as control), or 10 pi of an appropriately 
diluted stock solution of phytohemagglutinin (PHA; ICN), or Concanavalin A 
(Con A; Sigma) in RPMIc. All experiments were set up with a minimum of 
three replicate wells. The plates were incubated at 37 °C in a humidified 
atmosphere (5% CO2) for 3 days. The cellular proliferation was measured 
using either a tritiated thymidine incorporation assay or a 
3-(4,5-dimethylthiazol-2-yl)-2,5 diphenyl tétrazolium bromide (MTT) assay.
2.3.2.3. Tritiated thymidine incorporation
In order to measure cellular proliferation, tritiated thymidine incorporation was 
assessed. In this assay, 1 pCi tritiated thymidine (Amersham, specific activity 
25 Ci/mmol) was added to each well of a microtitre plate, 6 h (mitogen 
response), or 18 h (MLR) before the end of the culture period. The cells were
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harvested on glass filter paper using an ILACON cell harvester and a distilled 
water / methanol washer. After drying the filter paper discs in air, they were 
placed into vials containing 4 ml of scintillation fluid (BDH) and analysed 
using a liquid scintillation p-counter equipped with a line printer (LKB). The 
results were expressed as counts per minute (CPM).
2.3.2.4. 3-(4.5-dimethvlthiazol-2-vn-2.5 diohenvl tétrazolium bromide (MTT) 
assav
The colorimetric MTT assay involves the selective ability of living cells to
reduce the tétrazolium salt MTT to an insoluble product (formazan) via the
action of the mitochondrial enzyme succinate dehydrogenase (Slater etal,
1963). This conversion takes place only in living cells and the amount of
active
formazan produced is proportional to the number of^ells present (Mosmann, 
1983).
The basic protocol used in this study is based on Mosmann's method (1983) 
as modified by Denizot ef a/(1986). However, in preliminary experiments it 
was found that the suggested solvent (ethanol) did not achieve maximal 
solubilization of formazan crystals, even after agitation for 20 min. Thus, 
dimethyl sulphoxide (DMSO) was used as solvent, which achieved much 
better solubilization as evidenced by the disappearence of the purple 
formazan crystals in the wells (Twentymann etal., 1987)
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A stock solution was prepared at 5 mg/ml MTT in PBS and sterilised by 
passing through a 0.2 pm filter (Millpore) which also removed any insoluble 
crystals. The solution was stored in the dark at 4 until use when it was 
diluted in phenol red-free RPMI (RPMI-PR ) medium (Gibco, Paisley, UK) 
containing 1 mg/ml pyruvic acid.
Cells cultured in 96-well, flat bottomed, tissue culture plates were pelleted by 
centrifugation (800 g; 5 min), and the supernatant removed by carefully 
inverting the plates. Fifty microlitres of the MTT solution in RPMI-PR' (1 
mg/ml) was allquotted into each well, and the plates incubated at 37 °G for 3 
h. After centrifugation (800 g; 5 min), the non-reduced MTT was removed by 
carefully inverting the plates. Each well was supplemented with 50 pi of 
DMSO, and the plate agitated (plate shaker model R 100, Luckham) until 
complete solubilization of the formazan product occurred. The optical density 
of each well was measured using a plate reader (Multiskan MOO) fitted with a 
540 nm test wavelength filter.
2.3.3. ONE-WAY MIXED LYMPHOCYTE RESPONSE (MLR)
The one-way, mixed lymphocyte culture response (MLR) was used to assess 
the allogeneic reaction resulting from the interaction between CD4+ T 
lymphocytes and MHC class II antigen-presenting cells from genetically 
distinct individuals. Responding cells (PBMNC, or purified T cells isolated as 
described in Section 2.4.2.), were counted and adjusted to 1-2x10® cells /ml
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with RPMIc. Stimulating cells (either non-T PBMNC, or Mono Mac 6 cells) 
were treated in the dark for I h with 25 pg /ml (final concentration) of 
mitomycin C (37 °C). After washing three times in RPMI (400 g; 5 minutes) to 
remove residual mitomycin C, the cell suspension (100 pi) was added to the 
wells containing responder cells. Wells containing stimulator or responder 
cells alone with 100 pi RPMIc were set up as controls. The plate was 
incubated at 37 °C for 4-6 days and cellular proliferation assessed using the 
®H-thymidine incorporation assay described in Section 2.3.2.3.
2.4. ISOLATION OF DECIDUAL MONONUCLEAR CELLS 
(DMNC)
Decidual tissue was collected into RPMIc immediately after abortion and kept 
cool until delivered to the laboratory (usually within 3 hours). Samples were 
washed several times with PBS until free from blood and the tissue minced 
with scissors and strained through a stainless steel mesh. The dissociated 
cells obtained in this way were filtered through a sterile gauze to remove any 
clumps, and washed twice with PBS (400 g, 10 minutes). The cell pellet was 
resuspended in PBS and gently layered over a percoll gradient (Pharmacia, 
Sweden) as described by Starkey etal. (1988) and Norwitz ef a/.(1991). The 
constituents of the percoll solution is given in Appendix A. Briefly, the cells 
were resuspended in 36% Percoll in RPMI and layered over 62.5% percoll. 
This was overlayered with 5ml of PBS and centrifuged (760 g) for 30 min.
The top cell layer, which contained dead and many large cells, was
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discarded. The other layer (which contained the decidual mononuclear cells; 
DMNC) was harvested and washed three times in RPMI (400 g; 5 minutes). 
The total number of cells was counted and their viability assessed using 
trypan blue. Only those DMNC with a viability of greater than 95% were used 
in subsequent experiments.
2.4.1. PLASTIC ADHERENCE
In order to deplete macrophages, an aliquot of unseparated DMNC in RPMIc 
(3x10 ® cells /ml) were incubated in a plastic tissue culture dish (37°C; 5% 
CO^). The supernatant was aspirated and the plates washed. The aspirate 
and washing which contained the non-adherent cells were collected. 
Adherent cells were removed by cooling of the dish for 3-5 min at -20 °C 
followed by vigorous washing. The cells were harvested, counted and 
adjusted to a desirable concentration.
2.4.2. CELL SEPARATION USING THE MACS
2.4.2.1. Preparation of buffer and column
A magnetic activated cell sorter (MACS) was purchased from Miltenyl Biotel 
GMbH (Germany) and appropriate columns and needles were selected on 
the basis of the expected total number of positive cells.
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Although the standard buffer recommended by the manufacturer is PBS/
0.01 % sodium azide / 5mM EDTA /1 % PCS, the viability of cells separated In 
the presence of sodium azide has been reported to be decreased to 50-70 % 
on subsequent incubation (Pfiueger etal., 1990). Hence, sodium azide was 
omitted in all experiments.
2.4.2.2. Immunomaanetic staining and cell sorting
Mononuclear cells to be separated were washed with ice cold PBS twice and 
resuspended in buffer to which appropriate MoAbs conjugated to 
immunobeads were added. After incubation at 4 °C in the dark for 15 min, 
microbeads were removed by washing with ice cold buffer. Cells were 
resuspended in 1 ml of buffer and separated using the MACS.
Before operation, the column was autoclaved and rinsed several times with 
ice cold buffer, the final rinse being retained in the column for approximately 
30 min. Immediately before the separation, the column was washed again 
with ice cold buffer.
The sample was loaded on the top of the column under sterile conditions and 
allowed to pass into the column bed. Ice cold buffer was run through to flush 
the non-magnetic cells through the system. After extensive washing, the 
column was removed from the magnetic field, and rinsed with 10 times the 
volume of the column matrix. The cells flowing through the column were 
harvested as the "magnetic fraction".
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Immunobeads used in this study were CD3, CD4, CDS, CD14, plus an NK 
cell isolation kit. All immunobeads were purchased from Mittenyi Biotec, 
Germany. The efficiency of the separation procedure was assessed using the 
FACScan by labelling both the ’magnetic’ and ’non-magnetic’ fraction with 
appropriate MoAbs (Section 2.3.1.3.).
2.4.2.3. Depletion of T cells and macrophaces from DMNC 
NK cell-enriched populations were obtained using the MACS and the NK cell 
isolation kit microbeads. The kit includes a cocktail of modified CD3, CD4, 
CD19 and CD33 antibodies of mouse IgGI isotype to label non-NK cells. 
CD14 microbeads were also included.
Mechanically isolated DMNC (10® cells) were incubated with 625 pi of the 
buffer and 125 pi of reagent A ( Cocktail of modified CD3, CD4, CD19, CD33 
antibodies of mouse IgGI isotype to label non NK cells) in the dark at 4 °C for 
15 min. The cells were washed and the same amount of reagent B (Colloidal 
superparamagnetic MACS microbeads recognising Reagent A) and buffer 
were added to the sample. An aliquot of CD14-conjugated microbeads (50 pi) 
was also added. After 15 min incubation, the cells were washed (400 g; 5 
min), and immediately separated using the MACS as described in Section
2.4.2.2. The cells from both the magnetic and non-magnetic fractions were 
washed (400 g, 5 min), counted and their viability assessed using trypan
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blue. Only those cell fractions showing greater than 95% viability were used 
in subsequent experiments.
2.5. CHARACTERISATION OF CELLS PRODUCING 
IMMUNOREGULATORY FACTORS IN CULTURE 
SUPERNATANT
2.5.1. PREPARATION OF SUPERNATANTS OF SHORT TERM 
INCUBATION
DMNC, or their subpopulations, at an appropriate concentration (1-4 xIO® 
/ml), were dispersed into 24 well tissue culture plates (Nunc). The 
concentration of cells used was in keeping with the literature (Searle etal., 
1992; Wood etal., 1988; Norwitz etal., 1991). The cells, with or without 
stimulation (Con A or IL-2) were incubated at 37 °C for 3 days. At the end of 
the incubation time, the cell suspensions were transferred into Eppendorf 
tubes and microcentr i.fuged to pellet the cells. The supernatants were 
harvested, pooled and stored at -20 °C prior to use.
2.5.2. CHARACTERISATION OF CELLS PRODUCING 
IMMUNOREGULATORY FACTORS
The supernatants obtained were added in different volumes to the 
microcultures of Mono Mac 6 cells (2x10®/ml) for three days. The growth of
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the cells was measured using the MTT assay as described in Section 2.S.2.4. 
Control wells lacked decidual supernatants.
2.6. STATISTICS
Data were analysed using parametric and non-parametric tests where 
appropriate. Those tests used include the Student's t-test, the Mann-Whitney 
U test, and the Wilcoxon’s rank sum test.
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CHAPTER 3
RESULTS
SECTION 1. DEVELOPMENT OF ASSAYS TO MONITOR 
IMMUNOREGULATORY ACTIVITY OF DECIDUAL EXTRACTS
3.1 CORRELATION BETWEEN CELL DENSITY AND OD 540 nm
An MTT assay was used in this study to monitor the multiplication of cells, 
especially the growth of cell lines. To evaluate its reliability, a variable 
number of Jurkat E6.1 or Mono Mac 6 cells (in exponential growth phase) 
were allquotted in a flat-bottomed microplate and the MTT assay performed 
as described in Section 2.3.2.4. Analysis within an experiment of the 
relationship between the cell density and the optical density (OD) of each 
well showed a linear correlation (r = 0.98). This is keeping with the work
of others (Denizot etal, 1986; sladowski etal, 1993). Although the amount 
of MTT-formasan produced by the cells varied between one experiment 
and another. Fig 3.1-1 shows a representative result obtained from Jurkat 
E6.1 cells.
An MTT assay was used to assess the mixed lymphocyte response (MLR) in 
four experiments. The response was detected in only one experiment. The 
low sensitivity of this assay to measure cell replication may account for this 
result. Hence, the [^H]-thymidine incorporation assay was used for this 
experiment later on (see below 3.3, 3.4, 3.5).
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Fig. 3.1-1. Correlation between cell number and OD  
540 nm.
Various concentrations of Jurkat E6.1 cells in exponential 
growth phase were dispersed into microplates and incubated 
with 50 |ll of 1 mg/ml of MTT. After 3 h incubation formazan 
precipitate was dissolved in 50 |il of DMSQ.Each point is the 
mean and standard deviation from quadruplicate wells.
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3.2. MITOGEN INDUCED LYMPHOCYTE PROLIFERATION
Concanavalin A ( Con A) and Phytohaemagglutinin (PHA) are polyclonal 
activators primarily of T lymphocytes. They can stimulate a large proportion 
(sometimes as much as 70-80%) of susceptible lymphocytes. By interaction 
with specific sugar compounds on the lymphocyte membrane they trigger 
RNA and DNA replication, resulting in cell growth and proliferation (Sharm, & 
Lish, 1989). Whilst triggering T cells through a different route to antigen, 
mitogen stimulation provides a model which can be used to assess the 
immunoregulatory properties of decidual extracts. Thus, the response of 
human peripheral blood mononuclear cells (PBMNC) to Con A and PHA was 
standardised as described below.
3.2.1. TITRATION OF PHA AND Con A
A variety of concentrations of PHA (0.1-1 pig/ml) were added to PBMNC (200 
iLil; 10® cells/ ml in RPMIc). After culture for three days, cellular proliferation 
was assessed using the MTT assay (Section 2.3.2.4). It was found that PHA 
caused a dose-dependent stimulation of lymphocytes up to a maximum at 1 
pg/ml where the response plateaued (Fig 3.2-1). The mean increase at these 
concentrations was 55-60% compared with control cultures lacking PHA 
(mean +/- SD: 0.201 ± 0.021 in control; 0.311 ± 0.019, at 0.5 pg/ml; 0.321 ± 
0.068, at 1 pg/ml; and n=3). This is consistent with the literature which 
showed that 1 pg/ml was optimal concentration (Lang & Searle, 1994;
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Fig. 3.2-1. Dose response of PHA on lymphocyte 
proliferation.
Human PBMNC (2x10^ cells; 200 pi) were cultured in the absence or 
presence of various concentrations of PHA for 3 days. The cellular 
proliferation was measured with MTT assay. Each point represents the 
mean of quadruplicate cultures (standard deviation <20%) from three 
separate experiments.
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Stoeck etal., 1989). In keeping with literature, 1 pg/ml of PHA was used in 
subsequent experiments.
When various concentration of Con A (1-20 pg/ml)were added into the culture 
of PBMNC, it also caused a dose-dependent stimulation of lymphocyte 
proliferation with a maximal effect at 10 pg/ml (Fig 3.2-2). In comparison with 
PHA, Con A exhibits a more potent stimulation of the cells. The mean 
increase in OD at the optimal concentration was 156% compared to controls 
(mean +/- SD: 0.182 ± 0.073 in control; 0.467 ± 0.246, at 10 pg/ml; n=3).
3.3. MLR WITH U937 CELLS AS STIMULATOR
The mixed lymphocyte culture reaction (MLR) is an important assay in the 
study of allogeneic reactivity. In this assay, CD4 molecules expressed on 
lymphocytes from one individual recognise and respond to MHC class II 
antigen bearing cells from another unrelated individual. The cells expressing 
MHC class II antigens on their surface from PBMNC are monocytes, dentritic 
cells and B lymphocytes.
Different approaches have been made to study the reaction. For instance, 
dentritic cells isolated from PBMNC can stimulate the reaction very effectively 
(Knight et a/., 1986; Eales et a/., 1988). As terminal cells they do not require 
irradiation or treatment with mitomycin C to prevent their proliferation. 
However, dentritic cells only account for approximately 1-5% of PBMNC.
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Fig. 3.2-2. Dose response of Con A on lymphocyte 
proliferation.
Human PBMNC were cultured in the absence or presence of various 
concentrations of Con A for 3 days. The cellular proliferation was 
measured using an MTT assay. Each point represents the mean and 
standard deviation of quadruphcate cultures from tliree separate 
experiments.
67
Hence, the application of the protocol has been limited as a relatively large 
amount of blood from two individuals is required.
An alternative approach is to use an MHC class II expressing cell line as 
stimulator. Since IFNy can induce class II antigen expression in many cell 
lines, including several human monocytic cell lines (Watanabe etal., 1990; 
Shaked at a/., 1992), these cells have been reported to have the capacity to 
stimulate the proliferation of T lymphocytes (Shaked etal., 1992).
U937, a human myelomonocytic cell line, expresses many characteristics of 
monocytes, such as the release of lysozyme and myeloperoxidase (reviewed 
by Harris P etal., 1985). It has been reported that IFNy treatment induced 
these cells to express MHC class II molecules (Watanabe et al., 1990;
Shaked et al., 1992). Thus, the use of this cell line as stimulator in a MLR 
was investigated.
3.3.1. MODULATION OF HLA-DR EXPRESSION
U937 cells constitutively do not express HLA-DR antigens on their surface.
To induce their expression, the cells (5x10^ /ml) were treated with 0, 100,
300, and 5C ' '/ml of IFNy for 24 h and 48 h respectively. Cell surface antigen 
analysis (as described in Section 2.3.1.3) demonstrated that HLA-DR 
expression was induced by all concentrations tested in four experiments (Fig 
3.3-1).
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The time course showed that the effect of each dose after 24h incubation was 
greater than the corresponding dose after 48 h incubation in each of three 
experiments. One typical result is showed in Fig 3.3-2. It demonstrated that 
the median fluorescence was 73, 179, 235, and 245 at the concentrations of 
IFNy 0, 100, 300, and 500 u /ml respectively after 24h, and 65, 139, 201, and 
215 after 48 h. Hence, the cells were treated with 500 u/ml of IFNy after 24 h 
in subsequent experiments.
3.3.2. INHIBITION OF THE PROLIFERATION OF STIMULATORS
Mitomycin C is an anti-metabolic agent. It affects cells in exponential growth 
by preventing their division. Thus, it can be used to inhibit the proliferation of 
stimulator cells used in the MLR, thereby ensuring that any measure of cell 
proliferation may be attributed to the responder cells.
Conventionally, appropriate cells have been incubated with 50 pg/ml of 
mitomycin C (sigma) for 25 min (Knight, 1987) or 25 pg/ml for 60 min (Goto et 
ai, 1990). However, since U937 cells are a transformed tumour cell line, they 
may respond differently to mitomycin C when compared with non-transformed 
cells. Thus, in order to determine the concentration of mitomycin C required 
to effectively inhibit the stimulator cell growth, IFNy -treated U937 cells (10® 
/ml) were exposed to a range of concentrations of mitomycin C (5-50 pg/ml in
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Fig. 3.3-1. Dose response of IFNy on the induction of HLA-DR expression 
on U937 cells.
U937 cells (5x10 ^/ml) were treated with 0, 100, 300, and 500 Li/ml of IFNy 
for 24 h and 48 h respectively. The expression of HLA-DR was detected with
FACScan. ( control; . .. .100 u/ml; 300 p/m l;  500 u/ml.
A. 24 h; B. 48h).
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Fig. 3.3-2. Time course of IFNyon the induction of HLA-DR antigen 
expression on U937 cells.
U937 cells (5x10^ /ml) were treated with 0. 100, 300, 500 u/ml of IFNyfor 24 
and 48 h respectively. The mean of fluorescence was detected with the 
FACScan.
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RPMI) in the dark for 1 h at room temperature. After washing three times, the 
cells (5x10®/ml) were incubated for three days. A dose dependent inhibition 
of cellular proliferation was observed in all experiments. The lowest 
concentration of mitomycin C which totally prevented the growth of the cells 
in two experiments and caused 60% inhibition in another experiment was 20 
pg/ml. (see Fig. 3.3-3). Also, this concentration was the least toxic. It caused 
less than 50% cell death after treatment for three days, whereas higher 
concentrations caused greater than 60% cell death.
The dose response of mitomycin C on the growth of U937 cells was 
confirmed by cell cycle distribution analysis (see Section 2.3.1.2 for 
methodology). The cells were treated with or without various concentrations 
of mitomycin C (5-30 ug/ml) for 24 h in three experiments. One typical result 
is shown in Fig 3.3-4a. It demonstrated that maximal inhibition was observed 
at a concentration of 20 pg/ml. The percentage of cells in S phase increased 
from 25%, in the untreated, to 60% in the treated, cells. This change was 
reflected in a decrease of cells in G0/G1 from 68% in the untreated, to 28% in 
the treated, cells. A graph of the inhibition of DNA synthesis at the 
optimal concentration is shown in Fig. 3.3-4b.
In view of the effect of mitomycin C on both cellular proliferation and 
cytotoxicity, 20 pg/ml of mitomycin C was chosen and used in subsequent 
experiments.
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Fig. 3.3-3. Titration of mitomycin C concentration on the growth of 
IFNy treated U937 cells.
The cells were incubated with various concentrations of mitomycin C 
in the dark for 1 h at room temperature. After washing three times, the 
cells (5x10^/ml) were transferred into 24 well tissue culture plates 
and incubated for 3 days. Each point is the mean of duplicates count 
from three experiments.
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Fig.3.3-4(a). Dose response of mitomycin C on the cell cycle 
distribution of U937 cells.
IFNy -pretreated U937 cells were incubated with various concentrations 
of mitomycin C for 24. After washing three times, the cells were stained 
with propidium iodide and analysed with the FACScan. The figure is a 
typical result from three separate experiments.
c0>
LU
O
d
Q 2QQ E B B E B B
Fluorescence Intensity
Fig. 3.3-4(b). Effect of mitomycin C (20 pg/ml) on the cell cycle
distribution of U937 cells ( control; . . . .  IFNy only treated;_
IFNy and mitomycin 0 treated).
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3.3.3. USE OF U937 CELLS AS STIMULATORS IN AN MLR
Freshly isolated PBMNC were incubated at various concentrations with
0.6x10® U937 cells per well pre-treated with IFN^^and mitomycin C^or 5 days.
(500 u/ml) (20 |xg/ml)
Tritiated thymidine incorporation (See Section 2.3.3 for methodology) was
found to be directly proportional to the number of responder cells added in
three experiments. Maximal response was seen with 1.75x10 ®/well
responders (ratio of S to R was 1: 3; see Fig. 3.3-5).
When the number of stimulator cells was varied and the responder cells 
maintained at a constant level (1.5x10®/well), [®H]-thymidine incorporation 
after 5 days was highly variable. In five experiments, two showed an MLR, 
and three did not. The results are shown in Fig. 3.3-6.
To exclude the possibility that manipulation of the cell harvesting may have 
contributed to the variability observed, 10® U937 cells per well were 
Incubated with tritiated thymidine (1 |LiCi/well) for 4 h. The mean and standard 
deviation of CPM (x10'®) in 27 wells was 163 ±14. This is consistent with the 
data described by the manufacturer’s instruction manual (ILACON). This 
suggests that the variable results obtained were not the result of improper 
manipulation in cell harvesting.
75
CO
o
T“X
0_o
60
50
40
30
20
10
0
20
H3  Expt 1
—  Expt 2
-n—  Expt 3
PBMC (xio /well)
Fig. 3.3-5. Effect of amount of PBMNC on the one-way MLR.
IFNy and mitomycin C-treated U937 cells (0.6x10"^/well), along with
various concentrations of PBMNC were incubated for 5 days. Each 
point above represents the mean CPM from quadruplicate cultures.
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Fig. 3.3-6. Effect of amount of U937 cells on one-way MLR.
PBMNC (1.5x10 5/well), along with various concentrations of IFNy and 
mitomycin 0 treated U937 cells, were incubated at 37 oQ for 5 days. The 
cellular proliferation was measured with [3H]-thymidine uptake. Each point 
above is the mean of quadruplicate cultures from five separate experiments.
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3.4. MLR USING MACS-SEPARATED T LYMPHOCYTES AND 
NON I  CELLS
Conventionally, when PBMNC are employed in an MLR, they may be used 
either unfractionated, or fractionated into stimulator and responder 
population. The former has low sensitivity owing to the low density of 
alloreactive T lymphocytes and MHO class II antigen bearing cells. The latter 
requires other separation procedures, which are either time-consuming, or 
result in the partial loss of certain populations and therefore require relatively 
large volumes of fresh blood from two individuals. Thus, it is inconvenient to 
use these procedures routinely.
The MACS is a magnetic cell sorter used for the separation of a large number 
of cells according to their specific cell surface markers. Cells labelled with 
monoclonal antibody conjugated with magnetic microbeads are loaded on a 
column containing a steelwool-fibre matrix held in a powerful magnetic field. 
The negatively labelled cell populations flow through the column and are 
collected. Whilst the positive population is retained in the column. These 
cells are harvested by removing the column from the magnetic field and 
flushing it with buffer (Miitenyi et al, 1990).
Owing to the problem encountered using U937 cells as stimulators in an 
MLR, human PBMNC were separated into non-T cells (which include 
monocytes, B lymphocytes and dentritic cells) and T lymphocytes using the
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MACS and used as stimulators and responders respectively in a one-way 
MLR. The advantage of this system is that both the cells expressing MHC 
class II antigens and CD4 molecules may be collected for use.
3.4.1. ASSESSMENT OF THE EFFICIENCY OF CELL SEPARATION USING 
THE MACS
To prepare PBMNC for magnetic cell sorting, PBS was used throughout the 
separation procedure instead of RPMI to prevent the biotin in the medium 
affecting the procedure. The PBMNC (10 )^ were incubated with 20 \x\ anti- 
CD4 and 20 jliI anti-CD8 microbeads suspended in 80 pi cold buffer (PBS/ 5 
mM EDTA/1% PCS) and separated through an A2 column (the methodology 
was described in Section 2.4.2).
After the sorting, portions of the magnetic fraction (positive cells), and the 
non-magnetic fraction (negative cells), as well as unsorted cells were stained 
with FITC-conjugated anti-human CDS MoAb and analysed using the 
FACScan. This showed that before separation, the mean of CD3 positive 
cells accounted for approximately 55% of the isolated PBMNC. After sorting, 
this increased to 91% in the magnetic fraction; whilst only 8% of the non­
magnetic fraction were positive for CDS. Fig 3.4-1 shows the effect of the 
separation.
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Fig. 3.4-1. T cells enrichment of 7.5 x 10® PBMNC in a column of type 
A2.
The cells was sorted with CD4 and CD8 microbeads, and then
stained with FITC-CD3 mAb. ( nonseparated; . . . .  negative
fraction; postive fraction).
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3.4.2. STIMULATORY EFFECT OF DIFFERENT RATIOS OF STIMULATOR: 
RESPONDER CELLS
According to the standard procedure (Goto et al., 1990), the MACS-separated 
non-T cells from two unrelated donors were treated with 25 pg/ml (final 
concentration) of mitomycin C at 37 °C for 1 h. At the end of the incubation 
period, the cells were washed three times with RPMI and then adjusted to a 
concentration of 1x10® /ml in RPMIc. T lymphocytes were washed with RPMI, 
and resuspended in RPMIc to concentrations of 1x10® /ml, 1.5x10® /ml, and 
2x10® /ml.
Twenty-five microlitres of the stimulator cell suspension from individual A was 
dispersed into the wells of a round-bottomed microtitre plate. To each well 
was added 25 pi of a responder cell suspension from individual B. The 
rations of stimulator to responder was 1:1, 1:1.5, and 1:2 respectively. A 
second plate was set-up with stimulators and responders from the alternate 
individual. Wells containing only stimulators or responders and culture 
medium were used as background controls.
After 5 days culture, DNA synthesis was significantly higher than controls at 
all ratios of stimulator to responder cells (p<0.01, using Student’s T test; 
n=4). No significant difference was observed between the cultures containing 
different ratios of stimulators to responders (Fig 3.4-2).
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3.4.3. STIMULATION TIME COURSE
Stimulators (non-T cells; 2.5x10'* cells / well) and responders were cultured in 
different ratios for 4, 5, or 6 days. The [®H]-thymidine uptake showed that the 
MLR increased with length of culture. However, this increase only reached 
significance when stimulators and responders were cultured at a ratio of 1:1. 
At higher ratios (1:1.5 and 1:2) there was no significant difference in the 
proliferation between day 4 to day 6 of culture (Fig 3.4-3). This may be due to 
the limitation in nutrients at the higher cell densities.
3.5. ONE-WAY MLR USING Mono Mac 6 CELLS AS 
STIMULATORS
Mono Mac 6 is a well-characterised phagocytic cell line with many of the 
characteristics of mature peripheral blood monocytes and tissue 
macrophages, including the ability to produce cytokines upon stimulation, and 
the expression of CD14 and HLA-DR (Ziegler-Heitbrook etal., 1988). It 
provides another target to which CD4-positive T lymphocytes may react. In 
the later stages of the study this cell line became available and was used as 
a stimulator in the one-way MLR.
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1 :2
Fîg.3.4-2. Effect of ratios of stimulator to responder on 
one-way MLR.
The cells were cultured in the different ratios of S to R (indicated 
above) with 2.5x10 4 /well stimulator in a total volume of 50 pi 
for 5 days, including 18 h pulse with pH]-thymidine. The results 
are the means and standard deviations of triplicate cultures from 
four experiments.
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Fig. 3.4-3. Time course of the one-way MLR.
MACS-separated non T cells (stimulators) and T lymphocytes 
(responders) were cultured in the different ratios for 4, 5, or 6 days. 
Results are shown as the mean and standard deviation of tritiated 
thymidine incorporation expressed as counts per minutes (n=3).
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3.5.1. EXPRESSION OF HLA-DR ON MONO MAC 6 CELLS.
The expression of MHC class II antigens on Mono Mac 6 cells was examined 
using a phycoerythrin (PE)-conjugated anti-HLA-DR MoAb and flow 
cytometry. Fifty to sixty percent of the Mono Mac 6 cell line were positive for 
HLA-DR expression (See Fig 3.5-1).
3.5.2. STIMULATING EFFECT OF MONO MAC 6 CELLS IN AN MLR
Mono Mac 6 cells were pre-treated with mitomycin C (25 pg/ml) at 37 °C for 1 
h, and resuspended in RPMIc (1x10®/ml). Freshly isolated PBMNC (100 pi of 
1.5x10® cell / ml) were mixed with the stimulators (60 pi) at a ratio of 
stimulators (1) to responders (2.5) in a total volume of 160 pi per well for 5 
days. The results showed that Mono Mac 6 cells clearly stimulated an MLR. 
The proliferative response was significantly higher in wells containing both 
stimulators and responders than control wells containing either of the 
population alone (p<0.05 in one, p<0.01 in three experiments, using 
Student’s T test; n=3). However, in one experiment the responders alone 
showed a high background. Table 3.5-1 shows four separate experiments.
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Fig.3.5-1. HLA-DR expression on Mono Mac 6 cells.
The cells (10 ®) were stained with PE-conjugated anti HLA-DR MoAb or
anti mouse IgG isotype control ( . . .  . control; anti-HLA-DR
MoAb stained).
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Table 3.5-1. Effect of Mono Mac 6 cells as stimulators in an MLR.
PBMNC were incubated with mitomycin C treated Mono Mac 6 cells (25 
|jg/ml; 37 °C; 1 h) in a ratio of stimulator to responder 1: 2.5 with 6x10 4 
stimulator per well for 5 days. The total volume per well was 160 pi. The 
results were the means and standard deviations from triplicate cultures.
CPM ( x i o -3)
(mean +/- SD; n==3)
Expt Stimulator only Responder only Stimulator+Responder p*
1 2.4+/-1.4 25.8+7-9.4 47.2+/-12.2 <0.05
2 1.0+/-0.6 4.9+/-1.6 9.2+/-1.7 <0.01
3 1.8+/-1.7 7.0+/-1.8 16.9+/-0.8 <0.01
4 1.1+/-0.9 4.6+/-2.1 18.6+/-1.8 <0.01
between stimulators + responders and responders only.
87
SECTION 2. IDENTIFICATION AND PARTIAL 
CHARACTERISATION OF IMMUNOREGULATORY FACTORS 
FROM DECIDUA
4.1. THE IMMUNOREGULATORY EFFECT OF CRUDE 
DECIDUAL PROTEIN FRACTIONS (CDPF)
4.1.1. METHODOLOGY OF EXTRACTING DECIDUAL INTRACELLULAR 
PROTEINS
In order to extract intracellular soluble proteins from decidua prior to isolating 
any suppressive factors, it was necessary to disrupt the cells. Different 
approaches, including chemical, physical and mechanical are avilable for this 
purpose. The approach used here was homogenisation by which large 
quantities of decidua were disrupted in a short time (Section 2.1.2.1). To 
promote protein release, the homogenisation of samples was performed after 
freezing at -70 °C.
4.1.2. PREPARATION OF CRUDE DECIDUAL PROTEIN FRACTIONS.
After releasing intracellular proteins, cellular debris were removed by 
centrifugation (Section 2.1.2.1). The decidual supernatant obtained was 
concentrated and crudely separated with a Minitan ultrafiltration system using
molecular weight cut-off membranes with nominal exclusion rates of 10, 30, 
100 and 300 KDa. Thus, the crude decidual protein fractions (CDPR) with 
M.w approximately <10, 10-30, 30-100, 100-300, >300 KDa were obtained 
(see Section 2.1.2.2). When the total volume of the fractions obtained was 
compared to the total volume of the unfractionated supernantant, it was found 
that the individual fractions were concentrated by 1-4% (Table 4.1.1), which 
is consistent with the leaflet of the manufacturers (Millipore Corp, 1990).
4.1.3. PROTEIN CONCENTRATIONS IN CRUDE FRACTIONS
To determine the protein concentrations in each fraction, a standard curve 
was constructed by measuring the optical density at 725 nm of BSA solutions 
of known concentration using the modified Biuret reagent of Ohnishi and Barr 
(1978) for the Lowry procedure (1951 ). It showed that the absorbance at 725 
nm of the BSA solution was directely proportional to the protein concentration 
(r=0.98; Fig 4.1-1). The protein concentration of each decidual fraction was 
estimated using the standard curve (Table 4.1-1).
4.1.4. EFFECT OF CDPF ON MITOGEN-INDUCED LYMPHOCYTE 
PROLIFERATION
The fractionated CDPF, at a concentration of 10% (v/v), were added to PHA- 
stimulated lymphocyte cultures (Section 2.3.2.2). The same volume of PBS 
was added to controls. It showed that the fractions of 30-100 KDa and >300
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Fig. 4.1-1. Standard curve of protein concentrations at 725 nm.
The known protein concentration was prepared from bovine serum albumin.
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Table 4,1-1. Effect of preliminary separation and concentration of 
decidual supernatant with ultrafiltration system.
The decidual supernatant was initially filtered through two 10 KDa filters, 
generating < lOKDa fraction. The retentate was collected and filtered through 
two 30 KDa filters, producing a fraction with approximate molecular weight 
range of 10-30 KDa. In a similar manner, 30-100 KDa, 100-300 KDa, and 
>300 KDa fractions were collected by using appropriate membranes. The 
Protein concentration in individual fractions was estimated using a standard 
curve of protein concentrations at 725 nm.
a). First batch:
Volume of Protein concen- Total Yield
sample (ml) -tration (mg/ml) protein (mg) (%v/v)
Unfractionated 300 12.2 3660 100
<10 KDa 10 0.16 1.6 3.3
10-30 KDa 12 0.05 0.6 4.0
30-100 KDa 12 3.9 46.8 4.0
100-300 KDa 10 0.81 8.1 3.3
>300 KDa 256 7.5 1921 85
a). Second batch:
Volume of Protein concen- Total Yield
sample (ml) -tration (mg/ml) protein (mg) (%v/v)
Unfractionated 10.000 5.5 55,000 100
<10 KDa 100 0.16 16 1
10-30 KDa 100 0.19 19 1
30-100 KDa 120 1.3 1560 1.2
100-300 KDa 120 1.7 2040 1.2
>300 KDa 9,000 5.7 51,300 90
* The term 'first batch' and 'second batch' refer to two deferent decidua 
sample preparations. The 'second batch' was used for all the experiments 
using FPLC decidua fractions.
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KDa did not suppress PBMNC response to PHA. While the fractions of <10 
and 10-30 KDa significantly suppressed the cellular proliferation (<10 KDa 
culture: p< 0.01; 10-30 KDa: p<0.05; using Student’s T test). In addition, the 
fraction of 100-300 KDa slightly suppressed the response, but this did not 
reach significance (Fig. 4.1-2 A).
When the extracts were added at a concentration of a 20% (v/v), inhibition 
occured with the 30-100 and 100-300 KDa fractions. The >300 KDa fraction 
failed to inhibit the proliferative response to PHA (Fig 4.1-28). Since the 
control contained the same volume of PBS, it is unlikely that the inhibitory 
effect resulted from buffer toxicity.
4.1.5. THE EFFECT OF CDPF ON LYMPHOBLASTIC CELL LINE 
PROLIFERATION
A lymphoblastic cell line, Jurkat E6.1, was employed as a model to test the 
effect of CDPF on the growth of transformed T lymphocyte. The cells (200 pi; 
2x10 ^celis /ml) were cultured with CDPF fractions or PBS as control (10% 
v/v) for three days. Their growth was significantly suppressed in the presence 
of <10 KDa fraction (mean +/- SD: 0.80+/- 0.16 in control; 0.40+/-0.04 in <10 
KDa; p< 0.01 using Student’s T test). By contrast, the 10-30 KDa fraction had 
no inhibitory effect on the growth of E6.1 cells (mean+/-SD: 0.78+/-0.24); and 
the 30-100 KDa and 100-300 KDa fractions slightly enhanced the cell growth 
(0.95+/-0.26 in 30-100 KDa; 0.96+/-0.34 in 100-300 KDa; Fig. 4.1-3).
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Fig. 4.1-2. Effects of CDPF on PHA-induced lymphocyte 
proliferation.
PBMNC were cultured for 72h in the presence of 1 pg/ml of PHA, with 10% 
(A) and 20% (B) fractionated decidua extracts. The same volume of PBS 
was added to control culture. Cellular proliferation was measured using an 
MTT assay. The results are expressed as percentage proliferation (mean 
+/-SE) of control from three experiments, i.e. OD 540 test culture containing 
CDPF / OD 540 PHA-stimulated control x 100%.
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100-300 KDa
30-100 KDa
10-30 KDa
< 10 KDa
Control
OD 540 nm
Fig. 4.1-3. Effect of CDPF on the growth of Jurkat E6.1 cells.
Jurkat E6.1 cells (2x10 5 /ml) were cultured for three days in the presence of 
CDPF at a concentration of 10% v/v. Cellular proliferation was assessed 
using an MTT assay. The results ar expressed as the mean (+/-SD) of four 
separate experiments.
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Interestingly, these fractions exerted an inhibitory effect on the mitogen- 
induced lymphocyte proliferation assay as described in Section 4.1.4.
4.1.6. EFFECT OF CDPF ON THE PROLIFERATION OF 
MYELOMONOCYTIC CELLS
A myelomonocytic cell line, THP1, was used as a model to test the effect of 
decidual fractions on the growth of transformed monocytic cells. The cells 
were cultured (3x10f / ml) with CDPF or PBS as control (10% v/v) in a 24-well 
tissue culture plate for 3 days. The cell concentration in each individual well 
was then counted in duplicate. The <10 KDa fraction alone significantly 
inhibited the growth of the cells (p < 0.01, using Student’s T test). Fig 4.1-4 
shows the mean result from five experiments.
4.1.7. EFFECT OF THE <10 KDa FRACTION ON CELLULAR VIABILITY
The previous experiments demonstrated that the <10 KDa fraction inhibited 
mitogen-induced lymphocyte proliferation and the growth of Jurkat E 6.1 and 
THP1 cells. In order to examine this effect further, the cell cycle distribution 
and viability of Jurkat E6.1 cells were examined using propidium iodide 
(Section 2.3.1.2).
When Jurkat E6.1 cells were incubated with the <10 KDa fraction at various 
concentrations for 16 hours, ostensibly there was no change in cell cycle
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100-300 KDa
30-100 KDa
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Fig. 4.1-4. Effect of CDPF on the proliferation of THP1 cells.
The cells (3x10 5/mi; 1 ml/well ) were cultured with 10% (v/v) of each of CDPF 
for three days. The cell growth was measured with Coulter counter. The 
results are expressed as percentsge growth (mean +/- SO) against control 
from five experiments.
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distribution when compared to the control (Fig 4.1-5, A), although the treated 
cells tended to show a lower intensity of staining with PI. However, the cell 
viability was greatly decreased in a dose-dependent manner in those cultures 
containing the <10 KDa fraction. With 2.5%, 5%, and 10% of the fraction, the 
vaibility of the cells was decreased to 87.3%, 54.7% and 52.9% respectively 
(Fig 4.1-5, B). Hence, this would suggest that the decreased intensity may 
reflect changes in cellular DMA affecting its binding capacity for PI due to the 
induction of cyto lysis or apoptosis by the decidual fraction.
In order to investigate this further, more cell lines, including several 
monocytic lines (U937 and THP2), and a breast cancer (ZR75) cell line were 
employed to test the effect of the fraction on their growth. Using the same 
experimental conditions, it was found that the extent of suppression on these 
cell lines by this fraction was similar to that on Jurkat E6.1 and THP1 cell 
lines. Table 4.1-2 shows these results.
4.2. THE IMMUNOREGULATORY EFFECT OF PURIFIED 
DECIDUAL PROTEIN FRACTIONS
4.2.1. GEL FILTRATION CHROMATOGRAPHY
Crude decidual protein fractions with M.w. 10-30 and 30-100 KDa were found 
to be inhibitory to mitogen-induced lymphocyte proliferation in preliminary
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Fig. 4.1-5. Cell cycle distribution and cell viability of Jurkat E6.1 cells 
treated with <10 KDa fraction.
Cells were incubated in the presence or absence of various 
concentration of <10 KDa fraction for 16 h. The cell cycle distribution (A) 
and cell viability (B) were analysed simultaneously using propidim 
iodide.
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Table 4.1-2. Effect of <10 KDa fraction on monocytic (U937, THP1 and 
THP2), Jurkat E6.1 and breast cancer (ZR75) cell lines.
The appropriate cells were incubated with 2.5%, 5%, and 10% (v/v) of 
<10KDa fraction for 24h. The cellular growth was assessed using an MTT 
assay. The results were mean percentage growth as compared with PBS 
alone as control (n=3). The standard deviation is less than 15%.
% Growth
Volume of <10 Kda 
Cell lines
2.5% 5% 10%
THP1 81 15 15
THP2 96 21 18
U937 60 19 15
Jurkat E6.1 69 20 16
ZR75 83 41 28
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experiments (Section 4.1.4). To isolate the suppressive factors, these 
fractions were pooled, centrifuged, concentrated to 3-4 mg protein per ml, 
and applied to a Sephacry S-100 HR column connected to an FPLC system. 
The gel filtration chromatogram obtained (Fig. 4.2-1) showed a relatively high 
protein concentration in the >30 KDa region with three peaks. According to 
the standard curve of protein concentration absorbance at 280 nm (Fig 4.2- 
2), the protein concentration was 145 pg /ml in peak 1,140 pg /ml in peak 2, 
and 350 pg/ml in peak 3 respectively. Four relatively low peaks appeared in 
10-30 KDa region, their protein concentrations were between 25-50 pg/ml.
4.2.2. EFFECT OF DF ON PHA-INDUCED PBMNC PROLIFERATION
The fractions obtained from FPLC (DF) were added to PHA-stimulated 
PBMNC at a concentration of 10% (v/v). The cellular proliferation, as 
measured by [^H]-thymidine incorporation (Section 2.3.2.3), showed that the 
greatest suppressive activity was associated with one or more molecules of > 
70 KDa (large molecular weight fraction, LMWF; DF Numbers 6-11), with 
lesser activity associated with one or more molecules of approximately 7-20 
KDs (small molecular weight fraction, SMWF; fraction Numbers 38-44). The 
inhibition caused by both of the fractions was significant when compared to 
control cultures containing elution buffer alone (p< 0.01, compared with 
LMWF; p<0.05 compared with SMWF; using Student’s T test). The biggest 
inhibition achieved was almost 30% of the control (Fig 4.2-3). Other fractions 
did not significantly affect proliferation.
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Fig 4.2-2. Standard curve of protein concentrations against OD 
280 nm.
The known protein concentration was prepared from bovine serum albumin.
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Fig. 4.2-3. Effects of FPLC-separated decidual fractions on PHA- 
stimulated lymphocyte proliferation.
PBMNC (1x10 6/ml; 200|il) were stimulated with 2 p.g/ml of PHA for three 
days. The fractions, at a concentration of 10% (v/v), were added in triplicate 
at the beginning of the assay. Cellular proliferation was assessed by pH]- 
thymidine incorporation. The results were calculated using the equation 
CRM test culture containing DF
x100%
CPM PHA-stimulated control 
and expressed as the mean of proliferation of five separate experiments.
The standard deviation is less than 15% ( proliferation of PBMNC
stimulated with PHA alone and containing 10% v/v elution buffer).
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4.2.3. EFFECT OF DF ON ONE-WAY MIXED LYMPHOCYTE REACTION
The effect of those factors shown to have suppressive activity in the mitogen- 
stimulated lymphocyte proliferation assay (LMWF and SMWF) were tested in 
a one-way MLR. After five days incubation, cellular proliferation as measured 
by [^H]-thymidine incorporation was significantly suppressed (p <0.05 using 
Student’s T test). The mean percentage stimulation from six experiments was 
84% (± 4%) of that of conübl cultures in the presence of LMWF and was 88% 
(± 10%) in the presence of SMWF (Fig. 4.2-4).
4.2.4. EFFECT OF DF ON THE PROLIFERATION OF MONO MAC 6 CELLS
A monocytic cell line, Mono Mac 6, exhibits many characteristics of mature 
monocytes. In this study the effect of purified DF on these cells was 
investigated. After three days incubation, inhibition of the growth of Mono 
Mac 6 cells was more pronounced in the presence of LMWF than SMWF.
The former induced suppression of up to 40% of the control containing 
elution buffer alone (Fig 4.2-5).
4.2.5. EFFECT OF DF ON THE PROLIFERATION OF JURKAT E6.1 CELLS
In order to determine whether the effect of LMWF and SMWF on Mono Mac 6 
cells was related to their transformed state or to their cell type, the human T 
cell line Jurkat E6.1 was incubated with these fractions. No difference was
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Fig 4.2-4. Effects of LMWF and SMWF on the one-way MLR.
Mitomycin C-treated Mono Mac 6 cells and PBMNC (Ratio of stimulator and 
responder, 1:2.5) were cultured at 37oC for five days. Each of the fractions, 
at 10% concentration, was added, in triplicate, at the beginning of the assay. 
Proliferation was assessed by SR- thymidine incorporation. The data are 
expressed as the mean (+/-SD) of five separate experiments as compared 
with elution buffer as control.
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Fig. 4.2-5. Effects of FPLC-separated decidual fractions on the growth of 
Mono Mac 6 cells.
Mono Mac 6 cells (2x10 /^mI; 200 |il) were cultured for three days. The 
fractions, at a concentration of 10% (v/v), were added in triplicate at the 
beginning of the cultures. The growth of the cells was assessed using an 
MTT assay. The results were calculated using the equation 
OD 540 in test culture containing DF
x100%
OD 540 in elution buffer control 
and expressed as the mean growth in seven separate experiments. The
standard deviation is less than 18% ( the growth of the cells with
RPMIc alone and containing 10% v/v elution buffer).
1 0 6
found between the proliferation of control cultures and those exposed to 
LMWF in six experiments. Moreover, SMWF had a slight stimulatory effect on 
the growth of Jurkat E6.1 cells. Fig. 4.2-6 shows these results in relation to 
those obtained with Mono Mac 6 cells.
4.3. EFFECT OF ACIDIFICATION ON THE BIOLOGICAL 
FUNCTIONS OF DECIDUAL FRACTIONS
4.3.1. CHROMATOGRAPHY UNDER ACID CONDITIONS
The decidua-derived factors were found to inhibit the response of PBMNC to 
mitogens, an MLR, and the growth of Mono Mac 6 cells, but not the growth of 
Jurkat E6.1 cells. These effects show some similarity to those described for 
TGFpl (Section 4.5.1). It has been reported that immunosuppressive activity 
from murine decidua was associated with a molecule of 60-100 KDa when 
isolated under neutral conditions. This activity was largely enhanced after 
treatment of the decidua solution with acid; the suppressive activity being 
associated with a molecule of 13 KDa when isolated under acid conditions. 
This activity could be neutralised by an anti TGFp2 antibody and was thought 
to be a TGFp2 -related factor (Clark et al., 1985, 1988, 1990, 1992).
The LMWF isolated from human decidua had a molecular weight >70 KDa on 
gel filtration chromatography (Fig 4.2-1 ). To determine whether this was
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Fig 4.2-6. Effects of LMWF and SMWF on the growth of Jurkat E8.1 and 
Mono Mac 6 cells.
Both of the cells were cultured with 10% (v/v) of the fraction of interest for 3 days 
(2x10 5/ml; 200 p.l/well). The cellular proliferation was measured with MTT assay. The 
figures above are the mean from six experiments as compared elution buffer alone as 
percentage control, (The standard deviation is < 18%).
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identical to that detected in murine decidua, the concentrated crude decidua 
protein fraction with M.w. 10-100 KDa from the same batch was applied to the 
same column and separated under acid conditions (Section 2.1.3.2). The 
protein concentration of sample used was the same as that used under 
neutral conditions.
Fig 4.3-1 shows the chromatogram obtained under acid conditions. The 
majority of proteins of molecular weight >12 KDa was degraded. There were 
four protein peaks between 5 to 12 KDa. The elution volumes of the protein 
standards are marked on the top of the chromatogram.
4.3.2. EFFECT OF ACID FRACTIONS ON THE GROWTH OF MONO MAC 
6 CELLS
Purified TGFpi has been found to be a potent inhibitor of the growth of Mono 
Mac 6 cells (Uhm et al., 1993); an effect also seen with the decidual fractions 
separated under neutral conditions. If the LMWF contained inactive 
precursors of TGFp, the acidified fractions should exhibit a much greater 
level of suppression. In order to investigate this, acid fractions were added to 
the cultures of Mono Mac 6 cells with four volumes of the neutralizing agent 
(3.5 ml of 7.5% NaHCOs, 3.5 ml of DHgO, in 100 ml of RPMIc). In order to 
determine if dilution of the fractions by neutralisation had affected the results, 
the acidic elution buffer was used as control in each experiments. When 10% 
(v/v) of the individual fractions was added to Mono Mac 6 cultures, there was
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a slight reduction in ceil proliferation in the presence of fractions numbers 34 
to 40 (M.w. approximately 12 KDa), which caused 5% to 12% inhibition. 
However, none of these fractions achieved significant inhibition (p>0.05). 
Other fractions did not affect the cell growth. This would suggest that the 
suppression observed with LMWF and SMWF isolated under neutral 
conditions was not due to the presence of acid labile precursors of TGFp.
4.4. INVESTIGATION OF THE MECHANISMS UNDERLYING 
THE REGULATORY ACTIVITY OF DECIDUA FRACTIONS
Since both LMWF and SMWF have shown the ability to suppress the growth 
of Mono Mac 6 cells, the mechanisms underlying this activity were studied 
further by investigating the role of decidua fractions on cell cycle distribution, 
apoptosis, and MHC class II expression.
4.4.1. EFFECT ON CELL CYCLE DISTRIBUTION
The effect of both SMWF and LMWF on the cell cycle distribution of Mono 
Mac 6 cells was examined using a PI staining procedure (Section 2.3.1.2). As 
shown in Table 4.4-1, both fractions caused significant suppression of the 
growth of Mono Mac 6 cells after three days incubation. However, only the 
LMWF significantly affected cell cycle. By contrast, no obvious change in cell 
cycle distribution was observed in the presence of SMWF. These results
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indicate that the two decidua-derived fractions may affect the growth of Mono 
Mac 6 cells by different mechanisms.
Neither of the LMWF and SMWF affected cell viability (Table 4.4-1) 
suggesting that the observed decrease in cellular proliferation was not due to 
cytotoxicity.
4.4.2. EFFECT ON APOPTOSIS OF MONO MAC 6 CELLS
Apoptosis, also termed programmed cell death, represent a common 
mechanism involved in the regulation of the growth of cells and tissues. It is 
characterised by condensation of the chromatin, DNA fragmentation, and 
eventually cell disruption. The apoptosis-associated DNA fragmentation can 
be assessed by flow cytometry. When cells are stained with PI for cell cycle 
analysis, a distinct subpopulation of cells can be observed which express a 
hypodiploid level of DNA (below G0/G1), denoted as AO (Tetford etal., 1991; 
Zamai et ai, 1993).
In order to elucidate whether or not the decidual fractions inhibited the growth 
of Mono Mac 6 cells by inducing apoptosis, and eventually cell death, the 
cells were incubated with 10% of PBS, LMWF, or SMWF for 24h and 48h. No 
obvious change in AO phase was seen in the presence of decidual fractions 
after 24h incubation. After 48h incubation, SMWF-treated cells were not 
obviously different from the control [median (range): 3.5(1.70-5.96) in control;
11:
5.2 (2.41-6.70) in SMWF, n=8)] while LMWF-treated cells showed a 
significant increase in the AO region [6.8(1.79-16.59) in LMWF, n=8; p<0.05; 
statistical analysis was performed using the Wilcoxon signed rank test). Fig
4.4-1 shows these results.
4.4.3. EFFECT ON MHC CLASS II MOLECULAR EXPRESSION
In order to understand the effect of decidual suppressive factors on the 
expression of MHC class II molecules, Mono Mac 6 cells (which are MHC 
class II positive), were preincubated with the fractions (10%; v/v) for 24 h. A 
PE-conjugated MoAb raised against HLA-DR was employed to assess the 
expression. In general the expression in the treated cells did not differ from 
that of the untreated cells with either LMWF or SMWF [median (range) of FL: 
control, 611 (607-615); LMWF, 609 (578-664); SMWF, 594 (574-616); n=8]. 
This suggests that decidual suppressive factors do not down-regulate the 
expression of MHC class 11 molecules,
4.5. COMPARISON OF THE EFFECT OF TGFp AND DECIDUA 
FRACTIONS
Previous work in mice has demonstrated that an immunosuppressive factor 
derived from decidua was in fact TGFp ( Clark et al., 1990; Altman et al., 
1990). In order to determine whether or not the suppression caused by the
114
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median 3.5 6.8
Fig 4.4-1. Effect of LMWF on the percentage cells in AO region 
of Mono Mac 6 cells.
The cells (2x10 5/ml) were incubated with 10% of PBS (as control), or 
LMWF for 48h. The cells were then stained with propidium iodide and 
analysed with FACScan, The percentage of cells in the AO region was 
obtained from^DNA histogram.
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decidua-derived factors in this study are caused by TGFp. its biological 
functions were compared those of the decidua-derived immunoregulatory 
factors.
4.5.1. EFFECT OF TGFp ON IMMUNOREGULATION
Human platelet-derived TGFpl was purchased from Becton Dickinson (USA, 
lot No. 900503). According to the manufacturer's direction, 1 pg/ml of 
hTGFpi was diluted to 200 ng/ml in 36% acetonitrile (methycyanide, Fisons, 
Leicestershire, UK) / 0.1% trifluoacetic acid (TFA; Sigma), dispersed into 
polypropylene tubes and stored at -70 °C (stock solution). Immediately before 
use, the stock solution was diluted to the required concentration with culture 
medium.
Human TGFp2 was obtained from Crystal Chem, USA (Lot No. CR 7-042). It 
was diluted to 400 ng/ml in 5 mM HCI. Prior to test, it was diluted with RPMIc 
to give the required concentration.
4.5.1.1. Effect of hTGFBI on the one-way MLR
MACS-separated human peripheral blood T lymphocytes (Section 2.4.2) were 
cultured for 5 days with mitomycin C -treated, non-T cells from an unrelated 
individual at a ratio of 1:1.5 (stimulator: responder) with 2.5x10'^  stimulators 
/well in a total volume of 50 pi. The addition of various concentrations of 
TGFpi (range 0.02 ng/ml to 20 ng/ml) to the culture resulted in a
116
dose-dependent inhibition of proliferation as determined by the uptake of 
[^H]-thymidine. As shown in Fig 4.5-1, the maximal inhibition occurred at the 
concentration of 2 ng/ml (p< 0.01; using Student’s T test). The optimal 
concentration is in keeping with Kondo's work (1993).
4.5.1.2 Effect of hTGFBI on Mitooen-induced cell proliferation 
When human PBMNC were stimulated for 3 days with 1 pg/ml of PHA in the 
absence or presence of various concentrations of TGFpi, a variable effect 
was observed at the lower concentrations (0.02 - 0.2 ng/ml). As the dose 
increased (>2 ng/ml), a moderate suppression was observed in all 
experiments performed, this was most evident at a concentration of 20 ng/ml. 
In terms of percentage inhibition this corresponds to a median inhibition of 
9% to 17% (see Table 4.5-1). Owing to the variability between experiments, 
the results did not reach significance. However, all cultures containing 
TGFpl showed a response when compared to the untreated control.
4.5.1.3. Effect of hTGFBI on Human monocvtic and T Ivmohoblastoid cell 
lines.
THP1, a human monocytic cell line, expresses a range of antigens, including 
Fcyl (CD64), Fey 11 (CD32) and C3b receptor. These cells are phagocytic and 
can differentiate into macrophage-like cells in response to appropriate 
stimuli.
In this assay, two human monocytic cell lines; THP1, and Mono Mac 6, and 
one T lymphoblastoid cell line (Jurkat E6-1), were incubated in the presence
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Fig. 4.5-1. Effect of TGFR1 on the one-way MLR.
MACS-separated human peripheral blood T lymphocytes were cultured 
with mitomycin 0 - treated non T PBMNC from an unrelated individual for 5 
days. hTGF81 at varying concentrations (as indicated above) was added at 
the initiation of the reaction. The results are expressed as the mean and 
standard deviation of stimulation index (%) from four separate 
experiments.
** Significance p<0.01; * p<0.05 when compared with control using 
Student's T test
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Table 4.5-1. Effect of hTGFRI on PHA -induced PBMNC 
proliferation.
Human PBMNC (10 5 cells; 100 pi)) were challenged with 1 pg/ml of 
PHA. hTGFUl at varying concentrations was added at the initiation of 
the culture. Each number is the median of quardruplicate cultures 
expressed as counts per minute.
CPM (X10-3)
hTGFKI
(ng/ml) 0.00 0.02 0.2 2 20
Exp 1 31.2 35.7 32.2 30.8 25.8
Exp 2 42.8 35.9 34.4 34.6 35.9
Exp 3 57.0 56.5 66.2 53.2 51.7
Exp 4 37.8 43.0 39.6 34.7 30.0
median 40.3 39.4 37.0 34.6 33.0
range 31.2-57.0 35.7-56.5 32.2-66.2 30.8-53 25.8-51.7
P NS NS NS NS
NS. no significant difference.
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of different concentrations of TGFpi (0.02-20 ng/ml). No obvious change in 
the growth of Jurkat E6.1 cells was observed in the presence of TGFpi. In 
contrast to this, a slight inhibition of the growth of THP1 cells was observed 
(which did not reach significance) at the higher concentrations of hTGFpi 
(2-20 ng/ml). At lower concentration, its effect was variable and difficult to 
reproduce. However, hTGFpi clearly inhibited the growth of Mono Mac 6 
cells at a concentration as low as 0.2 ng/ml (p<0.05). Concentrations of 2 -20 
ng/ml reduced cellular proliferation by 40% when compared with control cells. 
Fig 4.5-2. illustrates these results.
4.5.1.4. Effect of hTGFB2 on the growth of Mono Mac 6 
Under the same experimental condition. Mono Mac 6 cells were exposed to 
hTGFp2 at various concentration (0.02-20 ng/ml) for three days. The growth 
of all the treated cells did not differ from that of control untreated cells in six 
experiments, although the magnitude of the optical density varied between 
one experiment and another. Table 4.5-2 shows these results.
4.5.2. PROLIFERATION OF MONO MAC 6 CELLS AND NEUTRALISATION 
WITH ANTl-TGFp ANTIBODY
Rabbit anti hTGFpi polyclonal neutralising MoAb (Becton Dickinson; Lot No. 
J792), goat anti hTGFp2 (R&D system; Lot No. EE212) and rabbit pan anti 
hTGFp (anti TGFpi and pS; R&D system; Lot No. E0033091) were diluted to
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Fig. 4.5-2. Effect of hTGF R1 on the growth of of Mono Mac 6, THP1, and 
Jurkat E6.1 cell lines.
Each of the cells (2x10 s/ml; 200 |il) was dispensed into a microplate and 
incubated for 3 days. hTGFfil at varying concentrations (ng/ml) was added 
to at the start of the culture. Cellular proliferation was assessed by an MTT 
assay, and results were expressed as % proliferation i.e., OD 550nm from 
cultures containing hTGFIil/ control cultures x 100%. Each column 
represents the mean and standard deviation of four experiments.
** Significance p<0.01; * p<0.05 when compared with control using 
Student’s T test.
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Table 4.5-2. Effect of hTGFR2 on the growth of Mono Mac 6 cells.
The cells (2x10 /^ml; 200 pi) were cultured for three days with various 
concentrations of hTGF(l2. Cellular proliferation was assessed with an MTT 
assay. Each number was the mean of triplicated cultures.
TGFI32
(ng/ml)
OD 540 nm
0 0.02 0.2 2 20
Expt 1 1.034 0.869 0.972 0.996 1.082
Expt 2 1.034 1.102 1.038 0.999 0.941
Expt 3 1.111 1.360 1.117 1.155 1.035
Expt 4 1.423 1.515 1.953 2.152 1.959
Expt 5 2.139 2.207 1.949 2.204 1.933
Expt 6 2.109 2.078 2.076 2.267 2.252
mean 1.475 1.522 1.518 1.573 1.589
+/-SD +/-0.523 +/-0.531 +/-0.523 +/-0.560 +/- 0.546
P NS NS NS NS
NS. no significant difference.
122
200 i-ig/ml with RPMlc, aliquotted, and stored at -20
Cultures of Mono Mac 6 cells (2x10^/ml; 200 pi) were supplemented with 
10% (v/v) PBS, LMWF, SMWF or 2 ng/ml of TGFpi and incubated for three 
days. Appropriate antibody was added at the start of the culture (final 
concentration 10 pg/ml). Inhibition of the growth of Mono Mac 6 cells by 
hTGFpl treatment was reversed (85%+/-17%) by the addition of anti- 
hTGFpi. By contrast, this concentration of antibody did not reverse the 
inhibition caused by either of the DF (Fig. 4.5-3 A). Adding the pan anti 
hTGFp antibody achieved the same results. In three separate experiments, 
anti-hTGFp2 polyclonal neutralizing antibody was added into the culture 
instead of anti-TGFpi. There was no reversal of the suppression caused by 
either of the decidual fractions or TGFpi (Fig 4.5-3 B).
4.5.3. CELL CYCLE DISTRIBUTION OF MONO MAC 6 CELLS AND 
NEUTRALIZATION WITH ANTI TGFp
The cells (2x10 /^mI) were cultured for 48h in the presence of 10% (v/v) of 
PBS, LMWF, SMWF or 2 ng/ml of TGFpi. Cell cycle analysis using a PI 
staining procedure (Section 2.3.1.2) showed that after 48 h incubation, 
TGFpi-treated cells tended to show a lower intensity of staining with PI. The 
number of cells in the G1/G0 phase, including in AO region were remarkably 
increased (mean %+/-SD: 55+/-2 in control; 72+/-4 in TGFpi; p<0.01); and
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Fig.4.5-3. Neutralization of hTGFBI biologic activity.
Mono Mac 6 cells (2x10 5 /ml) were cultured, in the presence or 
absence of 10 pg/ml of anti TGFBI(A) orTGFB2 (B) neutralizing 
antibodys, with 2 ng/ml of hTGFBI, or 10% v/v of LMWF, or SMWF 
respectively for 3 days. The growth of cells was measured with an 
MTT assay. The results are the mean from five separated experiments
(_______ the base line represents the growth of the cells in the
presence of appropriate agents without adding the Abs).
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decreased the number of cells in the G2/M phase (25+M in control; 8+7-4 in 
TGFp; p<0.01). Fig 4.5-4 shows the result.
To further investigate whether the suppressive activity caused by the LMWF 
was TGFpi related or not, rabbit, polyclonal, pan anti-TGFp1 neutralising 
antibody (final concentration, 10 pg/ml) was added to the cell suspension at 
the beginning of the culture. Analysis of the cell cycle showed that the 
addition of the anti-hTGFp1 antibody prevented the accumulation of cells in 
the G0/G1 phase and in AO region in those cultures treated with purified 
hTGFpl, but not those treated with LMWF (Fig 4.5-4). The histograms in Fig
4.5-5 shows a typical result.
Anti-TGFp2 antibody (10 pg/ml) was added into the cells treated with LMWF 
in two separate experiments, it did not reduce the cell distribution in G0/G1 
phase either (Table 4.5-3).
4.5.4. EXPRESSION OF HLA-DR MOLECULES AND NEUTRALIZATION 
WITH ANTI TGFpi ANTIBODY
It has been shown that LMWF and SMWF did not affect the expression of 
MHO class II molecules (Section 4.4-3). In this experiment the effect of 
purified TGFpi on HLA-DR was investigated, and compared with that of 
decidual fractions.
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Fig 4.5-4. Effect of anti-hTGFB1 neutralizing antibody on the cell 
cycle distribution of LMWF- and TGFB1-treated Mono Mac 6 cells.
The cells were incubated with 10% (v/v) of LMWF or 2 ng/ml of hTGFBI for 48h. 
The cell cycle distribution was analysed with PI staining. The results were 
expressed as mean (+/-SD) of percentage distribution from four experiments.
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Fig 4.5-5a. Neutralisation of hTGFRI activity on the cell cycle 
distribution and apoptosis of Mono Mac 6 cells.
Mono Mac 6 cells were incubated with 10% v/v of the LMWF or 2 ng/ml of 
purified TGFR1 for 48 h, with and without 10 pg/ml of anti TGFB1 
neutralising antibody. The cell cycle analysis was performed with PI
staining and FAC Scan (controls ; A.TGFfil....; B. TGFfil &
antibody....; 0. LMWF ; D. LMWF & antibody....).
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Fig 4.5-5b. Neutralisation of hTGFRI activity on the cell cycle 
distribution and apoptosis of Mono Mac 6 cells.
Mono Mac 6 cells were incubated with 10% v/v of the LMWF or 2 ng/ml of 
purified TGFIÏ1 for 48 h, with and without 10 pg/ml of anti TGFR1 
neutralising antibody. The cell cycle analysis was performed with PI
staining and FACScan (controls ; A.TGFI31....; B. TGFB1 &
antibody....; C. LMWF ; D. LMWF & antibody....).
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Table 4.5-3. Effect of antl-hTGFB2 neutralising antibody on the cell cycle 
distribution of LMWF-treated Mono Mac 6 cells.
The cells were treated with 10% v/v of LMWF with and without 1o pg/ml of 
the antibody for 48h. The cell cycle distribution was analysed using PI 
staining.
Expt Ab
% of Cells in Each Stage
G0/G1 8 G2/M
1 64 23 14
+ 62 24 13
2 - 64 23 13
+ 64 24 12
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When Mono Mac 6 cells were treated with 2 ng/ml of purified TGFpi, a 
significant suppression of HLA-DR expression was found after 24 hour 
incubation [median (range) of median fluorescence: control, 611 (607-615); 
TGFp, 576 (561-587); p<0,01, n=7]. Treatment with 10 |Lig/ml of neutralizing 
anti TGFpi antibody significantly reduced its suppression [TGFpi, 576 (561 
587); plus antibody, 596 (564-650); n=9; p<0.01. Statistical analysis was 
performed using the Wilcoxon signed rank test]. However, this antibody did 
not have an obvious effect on the expression of HLA-DR on LMWF and 
SMWF treated cells [LMWF, 609 (582-664); plus antibody, 600 (562-658); 
n=9. SMWF, 584 (574-616); plus antibody, 597 (570-642) ]. Fig 4.5-6 
illustrates these results.
4.6. CHARACTERISATION OF DECIDUAL FRACTIONS
In this study, SDS-PAGE analysis was employed to estimate the molecular 
weight of the decidual fractions of interest (Section 2.2.1). To further study 
the relationship between decidual fractions and TGFp, immunodetection of 
TGFp from the decidua fractions of interest was performed using Western 
blotting (Section 2.2.2).
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Fig 4.5-6. Effects of anti-hTGFB1 neutralising antibody on HLA- 
DR expression of DF-treated Mono Mac 6 cells.
The cells were incubated with 10% of PBS (as control), LMWF, SMWF and 
2 ng/ml of TGFB1 for 24 h respectively with or without 10 pg/ml of anti- 
hTGFBI. The expression was measured using an anti-HLA-DR MoAb (PE) 
and the FACScan. Results are shown paired with the median for each 
group.
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4.6.1. SDS-PAGE ANALYSIS
4.6.1.1. Analysis of LMWF
On a 12% polyacrylamide gel, a major band with a M.w. greater than 140 
KDa (the highest M.w marker in the protein standard range), and a minor 
band were detected under non-reducing condition. With 20 mM DTT to 
reduce the disulphide bonds, two bands were observed one with M.w similar to 
the minor band seen under non-reducing conditions, one with a very low M.w. 
Fig 4.6-1 (a) shows the results.
Using a logarithmic plot of the M.w. of the protein standards versus their 
relative electrophoretic mobility (Rf) and a regression formula (Fig 4.6-1 b), 
the M.w of each band was calibrated as follows: the minor band without DTT 
and that with DTT were 70 KDa, and the tiny band with DTT was 29 KDa.
In order to estimate the molecular weight of the major band more accurately, 
a 7.5% gel and large M.w standard were employed. Under these conditions, 
the major band appeared below 205 KDa (the highest M.w of the standard, 
see Fig 4,6-2). From the regression analysis of the standard curve, the M.w 
of the band was found to be 183 KDa (Fig 4.6-2, b).
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4.6.1.2. Analysis of SMWF
Due to the low protein concentration in the SMWF, it could not be detected 
with Coomassie brilliant blue staining. To enhance the effect of visualisation, 
the SMWF was concentrated 16 times with Microconcentrators before 
analysis. From Fig 4.6-3, it was showed that four bands were detected in the 
SMWF, having M.ws of 7, 9, 11, 14 KDa.
4.6.2. OPTIMISATION OF IMMUNODETECTION OF TGFp
Preliminary experiments showed that the LMWF was detected by both 
polyclonal rabbit pan anti- hTGF and an goat polyclonal Ab to TGFp2 
following staining with an HRP-conjugated secondary antibody. The SMWF 
did not bind either of these two primary antibodies. However, in control 
experiments, using Ab dilution buffer without the primary antibody, the 
"positive band" derived from the LMWF still existed. Thus, the following 
experiments were performed to minimise the background, non-specific 
binding and optimise the conditions of immunodetection.
4.6.2.1. Blocking non-specific binding sites
After protein transfer, non-specific binding sites on the blot were blocked 
before further processing. The blocking buffer used was TTBS recommended 
by the manufacturer of the primary antibody (R/D). In preliminary experiments 
5% dried, low fat milk was used as a blocking solution. However, it did not 
achieve a satisfactory effect. Increasing the concentration to 8%, or
133
1 2 3 4 5 6 7
Fig 4.6-1 (a, above). SDS-PAGE analysis of LMWF (12% gel).
Tracks from left to right: 1,.2,3, LMWF run under reducing conditions; 4, 
Standard of M.w. (bands from top to bottom: 140, 87, 48, 33, 29, and 21 
KDa respectively); 5,6,7, LMWF run under non-reducing conditions.
Fig 4.6-1 (b, below). Calibration of M.w. of LMWF under reducing 
conditions by the plot of relative eletrophoretic mobilities versus the 
logarithm of M.w for known protein standards.
M.w (KDa)
1000 1
y = 121.70 *  10A(-1.0732x) Ra2 = 0.899
100
0.2 0.6 0.80.0 0.4 1.0
Rf
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Fig 4.6-2 (a, above). SDS-PAGE analysis of LMWF with 7.5% gel.
Tracks from left to right: 1 Standard of large M.w. (bands from top to 
bottom: 205, 116, 97, 66, 45, 29 KDa respectively); 2,4, LMWF run under 
non-reducing conditions; 3. buffer control; 5, Standard of M.w. (bands from 
top to bottom: 140, 87, 48, 33, 29, and 21 KDa respectively).
Fig 4.6-2 (b, below). Calibration of Mw. of LMWF under non-reduced 
condition by the plot of relative eletrophoretic mobilities versus the 
logarithm of M.w for known protein standards.
M.w (KDa)
1000
y = 240.50 *  10A(-0.99456x) Ra2 = 0.979
100
10
0.20.0 0.4 0.6 0.8 1.0
Rf.
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Fig 4.6-3 (a, above). SDS-PAGE analysis of SMWF with 12% gel under 
non-reducing conditions.
Tracks from right to left: 1, Standard of M.w. (bands from top to bottom: 
140, 87, 48, 33, 29, and 21 KDa respectively): 2, h lG FIil (30 ng) in 1% 
BSA; 3, hTGFfJ2 (30 ng) in 5mM HCI; 4. LMWF; 5. SMWF.
Fig 4.6-3 (b, below). Calibration of Mw. of SMWF by the plot of relative 
eletrophoretic mobilities versus the logarithm of M.w for known protein 
standards.
M.w (KDa)
1000
y = 166.18 * 10^(-1.5456x) R^2 = 0.935
100
0.0 0.1 0.2 0.3 0.4 0.5 0.6 0.7
Rf.
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alternatively using 3% BSA, in addition to the 3% BSA contained in the 
antibody preparation, improved the blocking effect.
4.G.2.2. Titration of secondary antibodies
A goat anti-rabbit antibody (HRP-conjugated) was employed as the 
secondary antibody in the detection of hTGF(51 and (33. In order to determine 
the lowest concentration of the secondary Ab needed whilst minimizing non­
specific binding, the LMWF was incubated with various concentrations of the 
secondary Ab. A dot blot showed that in the control, without secondary 
antibody, the LMWF did not react with the ECL reagent. A 1:5,000 dilution did 
not prevent the non-specific reaction. With a dilution of 1:10,000 only minimal 
non-specific binding was observed with the LMWF (Fig 4.6.4 A).
A rabbit anti-goat antibody (HRP-conjugated) was used as secondary 
antibody for detection of hTGFp2. A dot blot showed a similar result to that 
described above, and a 1:10,000 dilution was found to be optimal for 
minimising the non-specific binding. (Fig 4.6.4 B).
4.6.2.3. Titration of the primary antibodies
To optimise the concentration of TGFpi antibody, the effect of 1 pg/ml and 
10 pg/ml of the antibody with various concentrations of secondary antibody 
was studied using a dot blot. It was found that at a concentration of 1 pg/ml of 
the antibody with a 1:10,000 dilution of the secondary antibody, minimized 
background, non-specific staining and detected 10 ng of purified TGFpi. As
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the concentrations of the primary and secondary antibody were increased, 
the background increased (Fig. 4.6-5 A).
Using 2.5, 5, 10 ng of hTGFp2, the highest concentration (10 pg/ml) of anti- 
hTGFp2 antibody used detected 10 ng of TGF2 following a 1:3000 dilution of 
secondary antibody (Fig 4.6-5 B).
4.6.2.4. Enhancement of signal with avidin-biotin amplification 
A difficulty encounted was that when blots were transferred from SDS- 
polyacylamide gel, the band of the purified TGFp control was very weak. To 
increase the intensity of staining, a biotinylated secondary antibody with 
extravidin (HRP-conjugated) were employed. Due to four binding sites with 
avidin for biotin, the signal from TGFp control was greatly improved. Fig 4.6-6 
summarised the conditions of these optimisation experiments.
4.6.3. DETECTION OF TGFp IN THE DECIDUAL FRACTIONS
Using the optimal conditions described above, it was found that the LMWF 
under both reducing and non-reducing conditions was still detected by 
antibody to TGFpi following secondary Ab staining, the bands of the SMWF 
and TGFp2 were not detected by this procedure. Purified TGFpi showed a 
band of M.w 25 KDa (Fig 4.6-7, a). Despite efforts to reduce the non-specific 
binding, parallel control experiments using antibody-dilution buffer only 
(without primary antibody), the LMWF still showed a strong band. By
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contrast, the 25 KDa TGFp band did not appear (Fig 4.6-7. b). Using anti- 
TGFp2 antibody as primary antibody, a similar result was obtained.
To exclude the possibility that the non-specific binding seen in the LMWF 
was due to the relatively high concentration of protein, another decidua 
fraction (No. 16) was used. This fraction had a greater protein concentration 
than LMWF but did not exhibit immunosuppressive activity. Fig 4.6-8(a) 
shows that fraction 16 had three bands on SDS-PAGE analysis. 
Densitometric analysis showed the bands to be 9829, 2415, 48260 arbitary 
units at absorbance 550 nm. That of the LMWF was 6016 under non­
reducing conditions; and 31778 under reducing conditions. When they were 
analysed by Western blotting, the band from DF 16 was negative, whilst that 
of the LMWF was “ positive”.
In order to determine the cause of the apparently non-specific staining of the 
LMWF, the primary Ab was omitted from the following experiments. In one 
experiment both the primary and secondary Abs were omitted and no signal 
was detected. This indicates that the LMWF did not possess inherent 
peroxidase activity. A second run which included the secondary antibody, 
produced a positive band as seen in the original experiments. In order to 
block potential non-specific binding sites on the LMWF, blots were pre­
incubated for 2h with 1:1000 or 1:500 dilutions of the secondary Ab (not 
conjugated to HRP) before being processed as before. Following detection 
with ECL, it was found that even the highest concentration of Ab used did not
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BFig 4.6-4. Titration concentrations of secondary antibodies.
Each pair (from left to right) containing 10 pi of 3, 6, 12 pg/ml of LMWF in 
each sample. The blots were blocked with 8% milk in TTBS, and then 
incubated with various concentrations of appropriate secondary antibodies: 
A: Goat anti rabbit IgG (HRP-conjugated). A1, 1:20,000; A2, 1:10,000;
A3, 1:5,000; A4, w/o antibody.
B. Rabbit anti goat IgG (HRP-conjugated). B1, 1:5,000; B2, 1:10,000;
B3, 1:20,000; B4, w/o antibody.
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Samples boiled in sample buffer for 5 min 
I
SDS-PAGE
I
Transfer the blot onto a nitrocellular membrane 
I
Blotting non-specific binding sites (3% BSA; 1 h)
I
Primary antibody (1 pg/ml in 3% BSA; 2 h)
I
Washing
I
Bioninylated secondary antibody (1:10,000 in 3% BSA; 1h)
1
Washing
I
HRP-conjugated Extravidin (1:10.000 in 3% BSA; 1h)
I
Washing
I
Detected by ECL
Fig 4.6-6. Optimised conditions for detection of TGFps by Western blotting.
142
in
CO
CM
10:59 19/01/95
m
CO
CM
•D0
$O
T3C0
CM
S
5LL
t
C
0
15X )
0
0  CM
"B  - o  5  5
<j> in CM . . .
R S
CO
-
i l l
c£  -2O) Û.'= 2  0
o 't I
X  0
O ) CO 
CO 
M"
s
OI-
<n
iX )
gcw  _  > *  _
0 QÛ
O ) ^C CO
'•p. x:
T3
1_g
.Q
2  I
IX3
II
II
- S ' -
1 ?
a .
R irLL co  —
. .  0
^  % CO 5IO) Q. CoCO
o
n
ck_
0*"#00
CO
JOJO0 CO0 £2 .c
0o  ÜD) 2
I S
0  
0
0 c 0O lu•”  O. <  CM CL
gœ
2 .» -  0
0 E
.o ' Œ cn
143
LO M
I
CO
CM
00
Eo
**- LL0TJCo 0 _ l
U )c $o
Ü "2 10V-H— 0"Oc o003 œ LL■o -
'o0
73 IcO )
_1
COE oo
**- 0
T— cC2 E o
U_ O
O
H i 5«*- Ü LLO 2 Pc . co a
"o T -CD CM
1" O
U_
g '0 '0
o *o y _c3 co CM"OE cE 0 0
0 aTJ ■oC O CO0 c3 COlU E CXDo E
<CL S' fe(/) CD
O Ûj M"C/) (3
< ÊCL 000 ÎÜ1<D to0 chQ 0JD
k_ CD 0D) 0 a.C 0
CD
co
03JO
0Q
ID
Q
144
Fig. 4.6-9.Assessment of the binding of LMWF to secondary 
antibody (HRP).
Each blot contained 10 pi of undiluted decidual fraction No. 16 (left) and 
LMWF (right). The blots were blocked with 8% milk, and then 1). directly 
detected with ECL reagents; 2). incubated with goat anti rabbit (HRP) 
1:10.000 for 1 h, and then detected with ECL; incubated with non­
conjugated goat anti rabbit 1:1000) (3) and 1:500(4) for 2h before being 
incubated with HRP-conjugated the antibody following detection with 
ECL.
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block the non-specific binding (Fig. 4.6-9). This would suggest that the 
positive reactions seen may have been due to some interaction between 
LMWF and HRP itself. Or that LMWF contains a molecule which acts like a 
rheumatoid factor of hDP200.
4.6.4. IMMUNODETECTION OF IMMUNOGLOBULINS
Kitano et al (1990) reported a decidua-derived immunoregulatory factor with 
a M.'w., of approximately 158 KDa was related to IgG. It was not clear 
whether or not the LMWF was identical to this factor. In this experiment 5pl of 
LMWF was subjected to Ouchterlony double immunodiffusion, using anti­
human IgG (y chain specific), anti-human Ig A (a chain specific), and anti­
human Ig M (p specific) Abs to detect. The concentrations of the Abs used 
were from 1:16 to 1:64 dilution. Normal human serum was used as a control 
in each case. It was found that no precipitin bands were observed with either 
anti human Ig G, Ig A. or Ig M. By contrast, the human serum control formed 
precipitin bands with each of the Abs used, (see Fig 4.6-10). To exclude the 
possibility that the negative result was due to a low protein concentration in 
LMWF, the fraction was concentrated 4 times in a microcentrifugator (the 
protein concentration was about 1 mg/ml). No precipitin bands were observed 
with the concentrated fraction either.
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4.6-10. Detection of human Ig G, Ig A, and Ig M from LMWF by 
Ouchterlony Radial immunodiffusion.
In the centre: ( A ) 5 pi of Ig G, ( B ). 5 pi of Ig A; ( C ). 5 pi of Ig M. In each 
circle the top left is human serum control; others are the LMWF (four 
time concentrated, protein concentration approximately 1 mg/ml).
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SECTION 3. PRELIMINARY INVESTIGATION OF THE ROLE OF 
NK CELLS IN THE IMMUNOREGULATION
In this study it has been shown that factors derived from first-trimester human 
decidua suppressed mitogen-induced lymphocyte proliferation, a one-way 
mixed lymphocyte reaction, and the growth of the human monocytic cell line, 
Mono Mac 6. By contrast, they did not inhibit the growth of the human T 
lymphoblastoid cell line, Jurkat E6.1. In order to determine which cells within 
the decidua produce these immunoregulatory factors, experiments were 
designed in which the supernatant from short term cultures of non­
fractionated and fractionated decidual mononuclear cells (decidua cell 
supernatant, DCS), was used to modulate the growth of Mono Mac 6 and 
Jurkat E6.1 cells.
Human first-trimester decidua contains many different cell subpopulations, 
any of which could be the source of the decidua-derived suppressive factors. 
Since the most abundant cells are CD56+ NK cells which have been reported 
to have immunosuppressive activity in vitro (Daya, ef a/, 1985; Nakayama, et 
al, 1985; Starkey, et al, 1988; Ferry, et al, 1990), the present study 
concentrated on the role of NK cells in the production of decidua-derived 
suppressive factors.
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5.1. METHODOLOGY OF EXTRACTING DMNC
In the last decade, the study of human decidual cells has became more 
commonplace and techniques have been developed in order to extract DMNC 
from decidual tissue. These methods may be divided into two categories. One 
is enzymatic dispersal using enzymes, such as collagenase (Ritson, et al, 
1987; Parhar, et al, 1988), collagenase plus dispase (Ferry, etal, 1990), or 
hyaluronidase (Starkey, etal, 1988). The advantage of this approach is that 
greater cell yields may be obtained. However, the treatment may alter the 
immunological properties of cells (Wood, et al, 1988), or may result in the 
selective loss of some cell types, such as CD4+ or CD8+ cells (Vince, et al, 
1990). The alternative approach is mechanical dispersal (Saito, etal, 1992, 
1993; Burrows, et al, 1993). The disadvantage of this technique is low cell 
yields, which may not be representative of the whole tissue. However, the 
cells are maintained in a in more physiological environment, and the 
technique avoids alteration of the immunological properties of cells (Wood, et 
al, 1988). Thus, in the current study, it was decided to use mechanical 
dispersal.
In early experiments, decidual cells were extracted by straining the tissue 
through a stainless steel mesh. Quite a few clotted clumps were seen 
macroscopically in the cell suspension. A large proportion of dead cells, as 
detected by trypan blue exclusion, and large non-lymphoid cells (glandular 
epithelial and stromal cells) were also seen in the cell suspension (Fig 5.1-1,
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a). After isolating mononuclear cells by a conventional density gradient 
centrifugation procedure, a few clotted clumps still appeared in the interface 
and the proportion of dead and large cells remained high (Fig. 5.1-1 ,b). In 
order to remove the clumps, a fine cotton gauze was used to filter the cell 
suspension, before it was layered over Ficoll-hypaque. A two-step percoll 
gradient method (see Section 2.4) was adopted in order to get rid of the dead 
and large cells (Starkey, ef a /1988; Norwitz, ef a /1991). Using these 
methods, the proportion of immunocompetent cells from DMNC was 
increased (see below Section 5.2). The cell viability was > 97% as 
determined by trypan blue exclusion.
5.2. CHARACTERISATION OF IMMUNOCOMPETENT 
DECIDUAL CELLS
Decidual mononuclear cells (DMNC) were isolated from first-trimester human 
tissue by mechanical dispersion and two-step percoll density-gradient 
centrifugation (Section 2.4). The immunocompetent cells of DMNC were 
studied by flow cytometry after labelling with appropriate monoclonal 
antibodies. The results of ten separate experiments, each containing more 
than four pooled decidual samples, showed that the mononuclear cells 
comprised 64% (median, range 37-73%) of the isolated DMNC. Among the 
mononuclear cells, CD14+ macrophages were found to be the most abundant 
cell type, accounting for 23% (range 12-43%) of the total population (Fig. 5.2- 
1).
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Fig 5.1-1. Mechanically-extracted decidual cells (a), and interface cells 
after Ficoll-hypaque separation (b).
The cell preparation was mixed with a equal volume of 0.2% trypan blue 
(Magnified 320x). The smaller cells are leukocytes (L), and large nuclear 
cells (stained blue) are non-leukocyte cells (N)or dead cells (D).
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CD56+ cells comprised 14% (range 6-61%); CD3+ T lymphocytes, 13% 
(range 6-23%) and GDI 6+ ceils comprised 5% (range 3-17%). By double 
antibody labelling, a small proportion of CD56+ NK cells also expressed the 
GDI6 antigen (3%; range 1-9%). These results were consistent with the 
findings by others ( Bulmer, 1989; Dietl, etal, 1992).
5.3. SUPPRESSIVE ACTIVITY IN THE DMNC CULTURE 
SUPERNATANTS
5.3.1. INFLUENCE OF CON A AND IL-2 ON THE GROWTH OF MONO MAC 
6 CELLS
The lymphocyte stimulators Con A and IL-2 were added to the cultures of 
DMNC to stimulate the release of immunomodulatory factors. However, these 
may influence the growth of Mono Mac 6 cells when the DCS are added to 
them. In order to eliminate this variable, the same doses of Con A (10 pg/ml), 
and IL-2 (25 p/ml) as those used in the culture medium of DMNC were added 
to Mono Mac 6 cells and their effect compared to that of TGFpi (2 ng/ml). 
After incubation for three days, it was found that neither Con A nor IL-2 
exhibited suppressive or stimulatory effects on the growth of Mono Mac 6 
cells (Table 5.3-1), while TGFpi significantly inhibited it (p<0.05).
153
0)U<D>
c/5OOh
(U
gI
80 -,
60 -
40 -
20 -
CD3 CD14 CD16 CD56 GDI 6+56
Fig. 5.2-1. Flow cytometric analysis of mononuclear 
cells from freshly Isolated DMNC.
The cells (5x10 5) were labelled with FITC-conjugated anti-CD3 
or CD16, or PE-conjugated GDI4 or CD56, and GDI 6 and GD56 
respectively. The number of cells positive for a given antibody 
was expressed as a percentage of total processed DIVING. The data 
are the results of ten experiments, each containing at least four 
pooled decidua samples. The bars represent the medians of each 
population.
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Table 5.3-1. Effect of Con A, IL-2 on the growth of Mono Mac 6 
cells as compared with that of TGFR1.
The cells (2x10 ^/well; 200 pi) were incubated with Con A (10 pg/ml), 
IL-2 ( 25 pg/ml), and TGF 13.1 (2 ng/ml) respectively for three days. 
The cellular growth was monitored with MTT assay. The results are 
the mean from triplicated cultures.
Expt OD 540 nm
Control TGFG1 Con A IL-2
1 1.266 0.931 1.292 1.246
2 1.111 0.818 1.101 1.174
3 1.110 0.660 1.076 1.120
mean 1.162 0.803* 1.156 1.180
+/-SD 0.090 0.136 0.118 0.063
* p<0.05 when compared to control using Student T test.
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5.3.2. SUPPRESSIVE ACTIVITY OF DCS
In this study DMNC, or subpopulations thereof (3x10 ®/ml in RPMIc), were 
divided into three fractions, one with 10 pg/ml of Con A, one with 20 p/ml of 
IL-2, and one with medium only as control. The cells were then incubated at 
37 ®C for 3 days. At the end of the incubation time, the cell suspensions were 
transferred into Eppendorf tubes and centrifuged to pellet the cells. The 
supernatants were harvested, pooled and stored at -20 ®C prior to use. The 
supernatants were added (in different concentrations) to Mono Mac 6 cells. 
After incubation for three days, a dose-dependent inhibition of Mono Mac 6 
growth was observed with all supernatants. DCS caused 17%, 38%, and 45% 
suppression (compared to control cultures) at concentrations of 12.5%, 25%, 
and 50% respectively (Fig 5.3-1). All these suppression are significant 
(p<0.05).
Comparing the cell growth in the absence and presence of the stimulators, it 
was found that supernatant from IL-2 treated cells did not increase the 
inhibition induced by untreated DCS. However, supernatant from Con A- 
stimulated cells enhanced the mean inhibition to 38%, 50%, and 61% at the 
concentrations of 12.5%, 25%, and 50% respectively, although it was not 
significantly different from that without simulators (p>0.05; see Fig 5.3-1 ).
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Fig. 5.3-1. Suppressive activity of the culture 
supernatants from DMNC on the growth of Mono Mac 6 
cells.
The cells were cultured at a concentration of 3x10 ®/ml in RPMIc, 
in the presence or absence of Con A (10 pg/m); or IL-2 (25 
pg/ml), for three days. The culture supernatants were harvested, 
and added into the appropriate microculture of Mono Mac 6 cells 
(2x10 5/ml; 200 pi) at different percentage of culture medium for 
three days. The growth of the cells was assessed with MTT assay. 
The results are the mean (+/-SD) of percentage growth against 
control from five experiments.
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5.3.3. COMPARISON OF DCS FROM ADHERENT AND NON-ADHERENT 
DMNC
Monocytes easily adhere to plastic surfaces, a property often used to isolate 
them from other PBMNC. It has been reported that macrophages are 
responsible for the production of prostaglandins by enzymatically extracted 
DMNC (Wood et al., 1988). In an attempt to get an NK cell-enriched 
subpopulation, DMNC (at a concentration of 3x10 ®/ml in RPMIc) were 
incubated in a plastic tissue culture dish at 37 *^C for 1h to allow the 
adherence of monocytes. The non-adherent cells were harvested and after 
washing, their concentration was adjusted to 2.5x10® /ml. The adherent cells 
were removed by vigorous washing (following cooling of the dish for 3-5 min 
at -20 ®C) and their concentration adjusted to 5x10®/ml. The culture 
supernatants harvested from both adherent and non-adherent cells showed 
similar levels of inhibition of Mono Mac 6 cell proliferation. Addition of Con A 
or IL-2 did not affect the potency of the resulting supernatant (Fig 5.3-2). This 
suggests that the adherent cells may be capable of releasing more of the 
regulatory factors than the non-adherent cells since far fewer of the former 
were used to prepare the supernatant.
Surface antigen expression of the separated cells was analysed using the 
FACScan. The adherent fraction, which should have contained mostly 
macrophages, contained a large proportion of CD3+ and CD56+ cells. 
However, the total recovery of CD56+ cells was decreased compared to the
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unfractionated cells (Fig. 5.3-2). This indicates that the procedure used was 
not efficient at separating monocytes from other cells.
5.3.4. EFFECT OF DCS ON THE JURKAT E6.1 CELLS
The current project has demonstrated that both LMWF and SMWF inhibited 
the growth of Mono Mac 6 cells, but not that of Jurkat E6.1 cells (Section 4.2). 
In order to determine whether or not the factors released from DMNC during 
short term incubation were responsible for this suppression, the supernatant 
from DMNC (adhesive, non-adhesive and non-separated) was added to Mono 
Mac 6 and Jurkat E6.1 cells for 72 hours. Compared with the medium control, 
the supernatant did not markedly suppress the growth of Jurkat E6.1 cells at 
a concentration of 25% (p>0.05). Compared with the effect on Jurkat E6.1, 
however, the supernatants from unfractionated DMNC, and Con A-treated 
non-adherent cells significantly inhibited the growth of Mono Mac 6 cells 
(p<0.05). At a higher concentration (50%), the growth of Jurkat E6. 1 cells 
was markedly inhibited. However, in each case it was less than that observed 
for Mono Mac 6 cells (Table 5.3-2). The supernatants from unfractionated 
DMNC, non-adherent, and IL-2-treated non-adherent decidual cells inhibited 
Jurkat E6.1 cells significantly less than that of Mono Mac 6 cells (p<0.05).
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Fig. 5.3-2. Effect of culture supernatant from adherent and 
non-adherent DMNC on Mono Mac 6 cells.
DMNC (3x10 6/ml) were incubated in 24-well plate at 37 °C for 1 hour; 
the adherent and non adherent cells were harvested. The appropriate DCS 
harvested after three days culture were added into microculture of Mono 
Mac 6 cells at a concentration of 50%. The cell growth was monitored by 
MTT assay. These results are the mean of percentage growth (+/- SD) 
against control from six separate experiments. Below is the subpopulation 
of adherent and non-adherent DMNC analysed with Flow cytometry. Each 
figure is the mean of two individual experiments.
Labelled Ab positive cells (%)
Before Sorting After sorting
Adherent Non-adherent
CDS 16 25 15
GDI 4 26 33 12
CD56 22 18 9
1 6 0
Table 5.3-2. Effect of culture supernatants of DMNC on the growth of 
Mono Mac 6 and Jurkat E6.1 cells.
Appropriate DMNC (3x10 ®/ml; non separated, plastic adherent or non­
adherent) were cultured with or without Con A (10 pg/ml) or IL-2 ( 25 pg/ml), 
for three days. The culture supernatants were added into the culture of Mono 
Mac 6 and Jurkat E6.1 cells at various concentrations. The cell growth was 
monitored using an MTT assay. Results are expressed as the growth index of 
decidua treated samples (calculated using the equation: 
abs of decidua supernatant treated cells
abs of control cells 
The data are represented as the mean growth index of six separate 
experiments.
Growth Index 
(+/-SD, n=9)
Supernatants
25% DCS added 50% DCS added
from MM6 E6.1 MM6 E6.1
DMNC 0.61+/-0.06 0.90+/-0.05* 0.53+/-0.08 0.68+/-Ü.06*
Non-adherent 0.92+/-0.04 0.98+/-0.01 0.63+/-0.10 0.75+/-0.01*
+Con A 0.58+/-0.10 0.92+/-0.02 " Q.50+/-0.13 Q.69+/-0.11
+IL-2 0.87+/-0.11 0.95+/-0.13 Ü.64+/-0.04 G.90+/-0.02*
Adherent 0.83+/-0.23 0.90+/-0.15 0.63+/-0.31 0.72+/-0.13
* p<0.05 showing a significant difference between the results obtained from 
Mono Mac 6 and Jurkat E6.1 cells cultures in the precent of the same volume 
of DCS.
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5.4. ROLE OF PROSTAGLANDINS IN SUPPRESSION
Prostaglandins have been shown to be responsible for the non-specific 
immunoregulatory activity associated with murine early pregnancy decidua. 
Macrophages and glandular epithelium were reported to be the cellular 
source (Mattews, ef a/, 1987; Wood, ef a/, 1988, Smith, ef a/, 1987). We 
investigated the role of prostaglandins in the suppression associated with 
DCS.
Indomethacin (an inhibitor of prostaglandin synthesis) was dissolved in 
ethanol (10 mM), and diluted in RPMIc into 100 pM. The final concentration 
used was 5 pM or 10 pM according to the literature (Matthews, ef al, 1987; 
Wood, ef al, 1988), and added at the start of DMNC culture. After three days, 
the supernatants were harvested and added to culture of Mono Mac 6 cells 
later, it was found that indomethacin-treatment did not eliminate the 
suppression caused by DCS from either the non-stimulated, or stimulated, 
adherent or non-adherent fractions (Table 5.4-1). As indomethacin alone did 
not affect the growth and viability of Mono Mac 6 cells in previous 
experiments, these results indicate that the suppressive activity derived from 
DCS is independent of the production of prostaglandins.
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Table 5.4-1. Effect of indomethacin-treated DMNC on the growth of 
Mono Mac 6 cells.
DMNC (3x10 G/ml; unseparated, plastic adherent and non-adherent) were 
cultured with or without Con A or IL-2 for three days. Indomethacin (final 
concentration 10 pM) was added into parts of these culture at the beginning. 
The appropriate supernatants harvested from these cultures were added into 
the culture of Mono Mac 6 cells at a concentration of 50%. The cell growth 
was assessed with MTT assay. The results are the mean (+/-SD) of 
percentage growth against control from three experiments.
Non-separated Non-adherent Adherent
Indomethacin + - + +
Non-stimulated 57+/-10 78+/-13 69+/-13 78+7-4 84+7-46 76+/-20
+ Con A 59+/-1 57+/-12 45+/-13 50+/-27 86+/-13 86+/-1
+ IL2 82+/-17 81+/-4 68+/-12 67+/-19 95+/-1 95+7-8
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5.5. THE ROLE OF NK CELLS IN SUPPRESSION
5.5.1. DEPLETION OF T CELLS AND MACROPHAGES FROM DMNC
The role of NK cells was studied by immunomagnetic depletion of cells 
bearing CD3, CD4, CD19, CD33 and CD14 (The protocol was outlined in 
Section 2.4.2.2.). The viability of > 95% was observed in both magnetic and 
non-magnetic fractions. The cell component in each fraction was analysed by 
flow cytometry using MoAb against CD3, CD14, and CD56 respectively. It 
was found that CD56+ NK cells were only slightly enriched in the non­
magnetic fraction (from 17% to 19%), despite a marked depletion of CD3+ 
lymphocytes and CD14+ macrophages. These latter two populations were 
enriched in the magnetic fraction (Fig. 5.5-1). Interestingly, the proportion of 
CD56+ cells was also enriched in this (Table 5.5-1). This is possibly due to 
the aggregation of cells, as a result of cell clumping.
5.5.2. EFFECT OF T CELL AND MACROPHAGE DEPLETION ON 
SUPPRESSION
The cells from the magnetic and non-magnetic fractions were adjusted to a 
concentration of 1.5x10®/ml, and incubated with or without stimulators for 
three days. The supernatant was added to cultures of Mono Mac 6 cells at 
different concentrations. It was found that supernatant from the magnetic
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fraction strongly suppressed the growth of Mono Mac 6 cells from a 
concentration of 30% (Fig. 5.5-2). The mean growth index of the cells 
exposed to supernatant from the magnetic fraction at a concentration of 50% 
was: without stimulator, 52% (+/-20%); stimulated with Con A, 44% (+/-24%); 
stimulated with IL-2, 42% (+/-4%). While in the presence of the same 
concentration of supernatant from non-magnetic fraction, the mean growth 
index was 97% (+/-10%), 86%(+/-11%), and 93%(+/-20%) respectively. 
Hence, the suppressive activity from T cell and macrophage depleted 
decidual cell population(non magnetic fraction) was remarkably decreased. 
However, since the magnetic fraction also contained higher proportions of 
CD56+ cells than the non-magnetic fraction, it is difficult to conclude which 
cells are the source of the suppressive factors.
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Fig 5.6-1. Depletion of CD3 lymphocytes and GDI4 macrophages in a 
column of B2 with MACS.
The DMNC were separated with NK negative enrichment kit plus GDI4 
microbeads, and analysed with FACScan (A, anti CDS MoAb staining; B,
anti CD14 MoAb staining; control; . . . magnetic positive fraction,
 magnetic negative fraction).
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Table 6.5-1.Effect of the separation of DMNC by using NK-negative 
enrichment kit plus CD14 microbeads.
The cells were labelled with appropriate Abs before sorting, and after sorting. 
The No. of cells positive for a given Ab was expressed as a percentage of 
total processed DMNC.
Labelled Ab % of positive cells
Before Sorting After sorting 
Magnetic Non magnetic
CDS 10 S4 2
CD14 12 S4 4
CD56 17 48 19
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Fig. 5.5-2. Regulatory effect of culture supernatants of NK and non 
NK cells on the growth of Mono Mac 6 cells.
DMNC were labelled with NK-negative enrichment kit plus CD14 
microbeads and separated with MACS. The cells from non-magnetic and 
magnetic fractions were adjusted to 1.5x10 ^/ml and incubated separately 
for three days. The culture supernatants were harvested and added to 
cultures of Mono Mac 6 cells at different concentration for three days. 
These results are the mean (+/-SD) of growth index against control from 
four separate experiments.
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CHAPTER 4
DISCUSSION
169
During normal pregnancy, the fetus is not rejected by the immune system of 
the maternal body despite bearing paternal MHC antigen. It has been 
proposed that this is due to the local production of immunoregulatory factors 
by the maternal decidua. Previous research showed that the cellé from 
human decidua can suppress immune responses (Golander etal., 1981 ; 
Nakayama etal., 1985; Matsui etal., 1989a). However, the factors 
responsible for maintenance of the fetus during early pregnancy and the way 
in which they mediate their regulation in humans have not been 
characterised. The present study was designed to investigate potential 
immunosuppressive factors from first trimester human decidua, to identify and 
characterise the factors which showed suppressive activity, and to identify the 
cells which produce them.
6.1. IDENTIFICATION AND PARTIAL CHARACTERISATION OF 
DECIDUAL FACTORS
In order to identify the suppressive factors, it was necessary to extract 
decidual intracellular proteins. Several approaches can be used for this 
purpose. Repeated freezing and thawing of the cells is a simple and gentle 
method, which results in extensive membrane lesions. It is thought that 
intracellular ice formation appears to be the major cause of membrane 
leakage. The "split' or 'holed' cells easily release their intracellular component 
(Harris E etal, 1990). One disadvantage is that proteinases may be activated 
and degrade the relevant proteins during thawing at 37 °C; and some
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exogenous proteinases derived from infection by microorganisms may also 
play a part. During the early stages of the study, this procedure was 
performed. However, it was found to be very time consuming and difficult to 
disperse the cells from large quantities of decidual tissue by the mechanical 
method prior to freezing and thawing the cells. Homogenisation was then 
used to promote intracelluiar protein release. The shearing pressure may 
cause dénaturation of relevant proteins, but it is thought to be reversible 
(Creighton, 1989). In order to minimise the protein inactivation, the decidua 
sampies were maintained at a low temperature (4 °C), and diluted with 
physiologicai buffer (PBS). Processing time was kept short to prevent DMA 
release and cell wall break up.
In order to concentrate the extracts an ultrafiltration system was used. It 
offers several advantages over alternative methods. For exampie, 
precipitation results in poor recovery; diaiysis and freeze-drying needs a 
longer processing time (Harris etal., 1990). In addition, ultrafiltration can 
crudely fractionate the proteins according to their M.w. allowing prescreeing 
of the filtrate to identify which molecular weight ranges contain the factors of 
interest and means that smaller volumes need to be used to purify the active 
molecules.
To investigate the suppressive activity of decidual extracts, it was necessary 
to establish immunoassays. The mixed lymphocyte culture response is an 
assay which is frequentiy used as a measure of T lymphocyte reactivity.
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Although a number of different techniques have been described, the most 
commonly used employs peripheral blood as a convenient source of cells. 
However, one of the drawbacteof the assay is that it requires a reiatively 
large amount of blood from at least two individuals for each assay. An 
alternative approach Is to use an MHC class II expressing cell line as 
stimulator. In the early stage of this study, none of them was available. But 
IFNy has been found to have the capacity to induce the expression of MHC 
class II antigens in several cells, including monocytic cell lines (Piacibello et 
a/., 1983; Harris P. etal., 1985). U937 cells have been reported to have a 
differential response to IFNy: HLA-DQ and DP expression being enhanced, 
whilst HLA-DR expression is unaffected (Shaked etal., 1992). In the present 
study, although the modulation of DO and DP expression by IFNy was not 
directly investigated, the expression of HLA-DR was found to be significantly 
enhanced (Fig 3.3-1 ; 3.3-2). This difference with Shaked’s group may be due 
to the use of different antibodies which recognise different epitopes on the 
antigen, or the use of IFNy which was obtained from a different source.
The study of IFNy-treated U937 cells as stimulators in an MLR showed 
equivocal results. The proliferation of responder ceils increased as their 
number was increased (Fig 3.3-5). However, when the responder population 
was kept constant and the stimulators increased, the results were very 
variable (Fig 3.3-6). Pulsing U937 cells in exponential growth phase with 
tritiated thymidine showed uniform uptake of [®H]-thymidine, eliminating the
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possibility that the observed variability was due to manipulation during the 
harvesting process.
The alloreactive immune response is dependent partly on the presence of T 
lymphocytes capable of recognising and responding to allogeneic MHC class 
II antigens, and partly on the quantitative and qualitative expression of MHC 
molecules. Since it is reasonable to believe that T lymphocytes from healthy 
donors would function normaiiy as responder cells, it is likely that the 
deficient MLR responses were due to the density of MHC class II antigens on 
U937 cells induced with IFNy not being sufficient to stimulate the reaction 
under the experimental conditions. It is also possible that IFNy activated celis 
may be secreting immunosuppressive factors eg PCs or cytokines, which 
subsequently inhibit the MLR. In addition, some MHC identity between the 
responder and stimulator cells may have existed, resulting in a reduced MLR. 
This inconsistency necessitated the use of alternative cells as stimulators.
Mono Mac 6 is one of a few human monocytic cell lines which naturally 
express high levels of MHC class II antigens. Hence, the ceiis may act as a 
target for alloreactive T lymphocytes. In the later stage of this study, this cell 
line was used as a stimulator in the MLR. Although the role of Mono Mac 6 
cells as stimulators in an MLR has not been documented previousiy, the 
results obtained from this study clearly show that the cells are very effective 
stimulators for alloreactive T lymphocytes, and the results are reproducible 
(Table 3.5-1).
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Obviously, the Mono Mac 6 cell line achieved better stimulation than the 
U937 cell line. This may be due to the level of expression of MHC class II 
molecule in the population as a whole, or on a per cell basis.
Non-T cells (comprising mainly monocytes and B lymphocytes) and T 
lymphocytes from human PBMNC were separated using the MACS and used 
in an allogeneic MLR. Purification was not very efficient (8% T cells were 
found in the non-T fraction) but a high recovery meant that only 10-15 ml of 
blood was required from each donor. The microbeads used did not affect the 
ceil viability or functionality This supports previous work showing that the 
cellular functions of natural killer cells and B lymphocytes are preserved 
during the separation (Abts etal., 1989; Pfiueger etal., 1990).
The contamination of the non-T population by 8% CD3+ T cells (Fig 3.4-1) 
was probably due to yô T cells which express CD3, but may not express CD4 
or CD8 (CD3+, CD4-, CD8- or +). Improved purity could be obtained, but at 
the expense of cell recovery . Since their presence did not dramatically affect 
the MLR, cell yield was given highest priority.
The effect of the total volume of the cell suspension on the reproducibility of 
the MLR was examined. It was found that, provided evaporation was 
prevented, as little as 50 |liI per well could give a sensitive and reproducible 
reaction. This ailows the use of smaller volumes of blood making the assay
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quicker. Actuaily, 20 |xl hanging drop cultures have been shown to give 
meaningful results (Knight, 1987).
In summary, the use of either the Mono Mac 6 cell line, or MACS separation 
of peripheral blood gave a high response, without the requirement for a large 
amount of blood.
Having established separation techniques and standardised the assays the 
effect of decidual fractions on them was investigated. In preliminary 
experiments, crude decidual protein fractions of 10-30, 30-100, and 100-300 
KDa were found to significantly inhibit mitogen-stimulated lymphocyte 
responses (p<0.05,10% of 10-30 KDa; 20% of 30-100 kDa, and 100-300 
KDa respectively, v/v). Further separation of the fractions of 10-30 and 30- 
100 KDa by chromatography showed that both LMWF (183 KDa) and SMWF 
(7-14 KDa) suppressed not only PHA-induced proliferation of PBMNC 
(p<0.01, LMWF; p< 0.05, SMWF; Fig 4.2-3), but also the one-way mixed 
lymphocyte reaction (p<0.05; Fig 4.2-4). Since control cultures contained the 
same volume of elution buffer as those treated with decidual fractions, the 
observed suppression was unlikely to be due to adverse effects of this buffer.
This study uses the method of direct separation of the suppressive factors 
from decidua homogenates. It differs from previous work using human 
decidua cell culture supernatants (Colander etal., 1981 ; Nakayama etal., 
1985; Matsui etal., 1989 a). However, this result is in agreement with
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previous work which showed that decidual cell supernatants inhibited 
mitogen-induced lymphocyte proliferation and the mixed lymphocyte reaction 
(Colander etal., 1981 ; Nakayama etal., 1985; Matsui etal., 1989 a).
The mitogen and MLR studies showed an effect of decidual extracts on T cell 
proliferation. However, when fractions were cultured with a transformed T celi 
line (Jurkat E6.1), inhibition of proliferation was not observed. By contrast, 
the transformed human monocytic cell line. Mono Mac 6, was inhibited by the 
fraction suggesting that the differences observed with primary and 
immortalised T cells were not due to the transformed state of the cells but 
possibly to a cell specific effect which, in the case of monocytes, would affect 
their ability to promote an immune response. This would also explain the lack 
of T cell proliferation in the mitogen and MLR studies.
As mentioned before. Mono Mac 6 cells have many of the characteristics of 
mature peripherai biood monocytes and tissue macrophages, including the 
expression of GDI 4 and HLA-DR. It is possible that these decidual factors 
may have a capacity of inhibiting the function of antigen presenting cells. This 
needsto be further investigated. However, this cell line provides a model for 
studying the mode of action of the suppressive factors further. In order to do 
so, the effect of these factors on the cell cycle distribution of Mono Mac 6 
cells, and the expression of MHC ci ass II molecules by them were 
investigated.
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When Mono Mac 6 cells were treated with the decidual fractions, it was found 
that the LMWF caused the cells to accumulate in the G1/G0 phase (Table
4.4-1). However, despite the ability of SMWF to suppress the growth of 
Mono Mac 6 cells, no change in the cell cycle distribution was observed in 
treated cells. This indicates that these two factors are distinct.
Additionally, the LMWF-treated cells showed a significant increase in the 
number of cells showing a level of DNA less than that observed in cells in 
G0/G1 after 48 h incubation (Fig 4.4-1). it has been suggested that this may 
represent cells undergoing apoptosis (Telford etal., 1991 ; Zamai etal.,
1993). Cell death by apoptosis (i.e. programmed celi death) is a major 
regulator of growth in normal tissues (Williams, 1991 ; Cohen, 1993).
However, whether the induction of apoptosis by the LMWF was independent 
of the stage of ceil cycle or was the result of the accumulation of ceils in the 
G0/G1 phase of the cell cycle, is not known. It has been suggested that there 
are two major control points in the cell cycle, one in late G1 (called START), 
where the cells becomes committed to replicate DNA, and one at the onset of 
mitosis or the G2/M boundary. A single gene, CDC 28 appears to be 
implicated in both the START and G 2/M transitions (Hunter, 1992). It is 
possible that the LMWF may inhibit the proiiferation of Mono Mac 6 cells by 
modulating either CDC 28 gene expression or the functionality of its product.
During pregnancy, decidua-specific proteins and peptides are produced in 
the uterine endometrium. More than ten proteins with diverse functions have
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been identified from early pregnancy decidua (reviewed by Halperin etal., 
1990). Some of these factors are thought to be associated with 
immunoregulation, such as TGFp, . . and PP14. The work presented
here shows that decidua-derived factors, one with M.w. 183 KDa and four 
bands with M.w. 7-14 KDa, were inhibitory to mitogen-induced lymphocyte 
proliferation, the MLR, and the growth of the monocytic cell line, Mono Mac 6, 
but not the lymphoblastic T-cell line, Jurkat E6.1.
The molecular weight of the isolated proteins did not appear to compare 
exactly to those of known decidua factors. However, the potential similarities 
between these factors and TGFp, the LMWF and hDP200, and the SMWF 
and TGFp stimulated studies to compare these factors.
Purified human TGPpi was added to MLR cultures and was found to inhibit 
the proliferation observed in untreated cuitures. This agrees with 
observations made in the murine system by Kondo ef a /(1993). In addition, 
TGFp was found to exert moderate inhibition of cellular proliferation in 
mitogen stimulated culture of PBMNC. This isagreement with the work of 
Stoeck ef a/ (1989) and Uhm ef a/(1993). Although the inhibition observed in 
the current study was less pronounced than that reported in the iiterature, this 
may be due to the iower dose of TGPp employed (2 ng/ml) compared to that 
reported to induce significant inhibition (25 ng/ml; Uhm etal., 1993).
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Jurkat E6-1 is an IL-2 producing T cell line. Since TGFp inhibited the growth 
of primary T cells, its effect on the Jurkat cells was examined. Interestingly, 
TGFp failed to effect the growth of Jurkat cells. By contrast, at a higher 
concentration, it siightly inhibited the growth of the human monocytic cell line 
THP1. However, the growth of another monocytic ceii line, Mono Mac 6, was 
markedly inhibited (Fig 4.5-2). This confirms that the effect of TGFp on 
cellular growth is cell line-dependent (Rizzino, 1987). The mechanism of the 
different response is far from clear yet. However, the Mono Mac-6 cell line 
was considered to be a useful model for studying the suppressive effect of 
TGFp further.
The majority of studies of the activity of TGFp were carried out using TGFpi, 
and only a few using TGFp 2 or p3. Previous studies have shown that they 
share very similar activity (Lyons etal, 1990). However, in the present study, 
in contrast to TGFpi, TGFp2 did not suppress the growth of Mono Mac 6 
ceils (Table 4.5-2). This would support the work of Cheifetz and colleagues 
(1987), who demonstrated that TGFpi and TGFp2 show distinct interactions 
with a family of receptors on target cells. They share a 280 KDa receptor, but 
only TGFpi, not TGFp2, interacts with both the 65 KDa and 85 KDa 
receptors. This would explain the distinct effect of TGFpi and TGFP2 and 
may explain the different responses to TGFpi observed with Mono Mac 6 
cells and Jurkat E6.1 cells, since the cell lines may express different 
receptors.
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TGFp is a well- characterised, immunosuppressive cytokine. Previous work 
has demonstrated that it may be involved in the survival of fetus allografts 
during early pregnancy. A TGF-p2-like immunosuppressive factor was 
detected in murine amniotic fluid (Altman etal., 1990). Moreover, both 
TGFpi and P2 activity were detected in human amniotic fluid (Lang & Searle, 
1994). Although the precise celluiar source of these factors has not been 
defined, they are though to play an important role in regulating maternal 
immunity during pregnancy.
In murine decidua, Clark and his colleagues have demonstrated an 
immunosuppressive molecule related to TGFp2 (Clark etal., 1988,1990; Lea 
etal., 1992). Recently, CD56+ NK cells were reported to be the source of 
TGFP2 production (Clark etal., 1994). Another group (Temada etal., 1990) 
found that TGFpi was expressed in mouse decidua, and epithelia cells were 
found to be the primary sites of TGFpi synthesis. In humans, TGFp (pi and 
P2)-specific immunostaining was demonstrated In situ in the glands and 
stroma (Selick etal., 1994), and in the extracellular matrix of first trimester 
decidua (Graham etal., 1992). However, this study did not try to demonstrate 
the biological activity of TGFp in these tissue.
The decidua-derived factors observed in the present study showed some 
similarity in their biological activity to TGFpi. In murine decidua, 
immunosuppressive activity was shown to be associated with a molecule of 
60-100 KDa when chromatographed under neutral conditions (Clark et al..
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1988), but was associated with a fraction of M.w. 13 KDa under acid 
separation conditions. In order to determine whether the LMWF presented 
here might be a precursor of TGFp, the fractions were isolated under acid 
conditions, only slight inhibitory activity was demonstrated after the acid 
treatment (5-12%); much lower than that exhibited by the LMWF separated 
under neutral conditions (Section 4.3-2). Previous work has shown that 
acidification activates latent TGFp (reviewed by Lyons etal., 1990), and 
when murine decidua fractions were treated this way, the immunosuppressive 
activity of the fraction was greatly increased (Clark etal., 1988). This would 
suggest that the LMWF isolated in the present study is not a precursor of 
TGFp. Further work using a rabbit anti-TGFp antibody (against TGFpi and 
TGFps) aboiished the effect of purified TGFp on the growth and cell cycle 
distribution of Mono Mac 6 celis, but did not affect the activity of the LMWF at 
all (Fig 4.5-3, 4.5-4, & 4.5-5). It is possibie that the ultrafiltration separation 
procedure used in the current study eliminated TGFp (due to its noted abiiity 
to be absorbed on membranes and plastic surfaces), allowing other 
immunosuppressive molecules to be identified.
Since the SMWF had a molecular weight of 7-14 KDa under neutral 
conditions (Fig 4.6-3). it was possible that it might be a TGFp-reiated factor. 
However, neutralising anti-TGFpl and p3 antibodies did not affect its 
suppressive activity (Fig 4.5-3A) and Western blot analysis did not detect any 
TGFpi in the SMWF (Fig 4.6-7). Thus, it is unlikely that the factor is TGFpi. 
in addition, since purified TGFp2 did not inhibit the growth of Mono Mac 6
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cells (Table 4.5-2), as did the decidua-derived factors and this inhibition 
could not be reversed by the use of neutralising anti-TGFp2 antibody (Fig
4.5-3B), it is unlikely that either the SMWF or LMWF are TGFp2.
In 1990, Halperin and his colleagues (1990) reported a new human decidua 
associated protein. Under non-reducing SDS-PAGE analysis, it appeared as 
a single protein band with molecular weight of approximately 200 KDa 
(hDP200). Under reducing conditions it formed two polypeptide chains with 
molecular weight of 55 and 25 KDa. When analysed by SDS-PAGE, the 
LMWF appeared to have similar M.w bands: under non-reducing conditions, 
183 KDa; under reducing conditions, 70 and 29 KDa; raising the possibility 
that the immunosuppressive LMWF is hDP200. Recently, Halperin eta l 
(1994) demonstrated that the human-decidua associated protein hDP200 was 
a rheumatoid factor. Amino acid sequencing of the N-terminal region 
suggested that this factor is IgG. Western blot analysis demonstrated heavy 
chains of IgA, IgG and IgM associated with hDP200. However, Western blot 
analysis in the present study suggested that although the LMWF non- 
specifically binds, to horseradish peroxidase (HRP) conjugated antibodies, 
this could not be blocked by preincubation of the biot with high 
concentrations of the unlabelled antibody (Fig 4.6-9).
The amino acid sequencing performed by Halperin ef a/does suggest that 
hDP200 is an IgG-like molecuie. Moreover, another group has shown that 
human decidua extracts inhibited mitogen induced proiiferation of PBMNC,
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and the causative factor (M.w 158 KDa) is thought to be IgG or a substance 
copurified with igG as demonstrated by immunoelectrophoresis and double 
immunodiffusion (Kitano etal., 1990). In the present study, the Ouchterlony 
double diffusion technique did not demonstrate the presence of heavy chains 
of IgG, IgA, or IgM in LMWF (Fig 4.6-10) even after concentration of the 
LMWF to four times that used in the Western blot analysis. This suggests 
that the LMWF may not be identical to hDP200 or the 158 KDa factor, Ig G.
The SMWF identified from this study has a similar molecular weight to 
placental protein 14 (PP14) which was initially isolated from human term 
placenta with subsequent studies indicating that its main site of synthesis 
during pregnancy is the decidua (Julkunen etal., 1988). Glandular epithelial 
cells in human decidua are the celluiar source of PP14 (Reviewed by 
Seppala etal., 1994) which was found to have immunosuppressive 
properties; it inhibited allogeneic (Bolton etal., 1987), mitogen or IL-2 
induced iymphoproliferation and NK activity (Pockiey etal., 1988; Okamoto et 
al., 1991). it has been suggested that its inhibition is mediated by decreasing 
the production of IL-1 (Pockiey etal., 1990), and IL-2 (Pockiey etal., 1989), 
Thus, PP14 shares biological activities with SMWF. However, purified PP14 
is a 42 KDa glycoprotein (reviewed in Pockiey etal., 1990), migrating as a 28 
KDa band on SDS-PAGE (Julkunen etal., 1988), whereas SMWF appears as 
four bands between 7-14 KDa. Thus, the SMWF is unlikely to be PP14.
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Other low molecular weight substances have been associated with 
immunosuppression and decidua. Prostaglandin E2 has been well 
documented as a non-specific immunoregulatory factor from murine early 
pregnancy decidua. It inhibited antigen- and mitogen-induced iymphocyte 
proliferation, MLR, CTL (Mattews & Searle, 1987; Wood etal., 1988) and NK 
cell activity (Malygin etal., 1993). Recently, an endogenous inhibitor of 
prostaglandin synthesis has also been found in human decidua (Sun etal.,
1994). However, since the M.w. of prostaglandins is less than 1 KDa, the 
immunosuppressive activity observed in the present study could not be 
caused by these chemicals.
6.2. INVESTIGATION OF THE ROLE OF NK CELLS IN 
DECIDUA-ASSOCIATED IMMUNOREGULATION
In order to study the role of immunological cells in the immunosuppression 
associated with human decidua, it was first necessary to develop a method 
for their separation. Mechanical, rather than enzymatic, dispersal was used to 
dissociate decidual cells in order to avoid alteration of the immunological 
properties of the cells. Others have shown that cells obtained mechanically 
are generally smaller than those derived enzymatically (Wood etal., 1988); 
implying that cells obtained mechanically contain a relatively high proportion 
of immunocompetent cells, since decidual glandular epithelial and stroma 
celis are large. However, in the present study, mechanically dissociated celis 
were mostly dead and contained a high proportion of large cells. Thus, a
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two-step percoll gradient separation (62%/31 %/PBS) was modified from a 
previously reported method (Starkey ef a/., 1988) to eliminate the dead and 
large cells. Using this method, the yield of immunocompetent decidual cells 
was higher (on average 65% of DMNC) with greater viability (>97%).
When cells isolated in this way were analysed by flow cytometry, it was found 
that an average of 65% of DMNC were immunocompetent cells (including 
macrophages, NK cells, and T lymphocytes). This is slightly different from 
previous work: Starkey efa/(1988) showed a higher proportion (75%); whilst 
Vince et al (1990) showed a lower proportion (47%). This may be due to the 
different methodologies employed in extracting DMNC.
Among the immunocompetent cells, CD14+ macrophages were found to be 
the most abundant cell type (23% of DMNC), followed by CD56+ NK cells 
(14%), and CD3+ T lymphocytes 13% (Fig. 5.2-1). This is opposite to 
previous reports (Starkey etal., 1988) which suggested LGL were the most 
abundant cell type. One reason for this discrepancy may be that the overnight 
incubation during enzymatic digestion allowed the loss of macrophages due 
to adherence. On the other hand, the process of enzymatic digestion may 
cause the selective loss of specific cell types, or membrane marker antigens.
The majority of NK cells were found to be CD56+ CD16- with only a small 
proportion being CD56+ and CD16+. This is consistent with the observation 
of others (Starkey et al., 1988).
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To determine whether or not NK cells were responsible for the 
production of the immunosuppressive factors, the cells had to be purified 
further. This was done by the use of an NK-negative enrichment kit and the 
MACS magnetic cell separator. The contamination of the non-magnetic 
fraction by T lymphocytes and macrophages was very low (Fig 5.5-1 & Table
5.5-1). This is consistent with the observation of others (Pfiueger et a/, 1990) 
who have demonstrated a 2-9% contamination of CD3+ cells following the 
negative separation of NK cells from peripheral blood. However, in the 
present study, this negative selection procedure did not enrich the NK cells in 
the non-magnetic fraction which still contained a large proportion of decidual 
stromal cells. Also, many NK cells were retained in the magnetic fraction. 
This may be due to the expression of adhesion molecules on the NK cells, 
such as fibronectin receptors, and p2 intergrins (Burrows etal., 1993), or due 
to ceil clumping.
Both separated and non-separated cell fractions were cultured for short 
periods of time and their supernatants assessed for immunosuppressive 
activity. The cells from human decidual tissue, or the mediators released by 
them in short-term culture, have been found to suppress mitogen-induced 
lymphocyte proliferation and MLR (Golander, etal, 1981 ; Parhar, etal, 1988; 
Matsui, etal, 1989 a & b). In the present study, the supernatant from short­
term cultures of DMNC (non-separated and separated) was similar to that 
observed with the decidua extract. They suppressed the growth of Mono Mac
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6 cells in a dose-dependant manner. However, they did not affect the growth 
of the T lymphoblastoid cell line Jurkat E 6.1 at a lower concentration. At 
higher concentrations they inhibited the cells but the effect was much less 
than that observed with Mono Mac 6 cells (Table 5.3-2).
The treatment of DMNC with IL-2 did not increase the observed suppression 
(Fig 5.3-1). It is possible that the celis which produce the suppressive factors 
are IL-2-independent. Alternatively, since pooled decidual cells were used to 
produce the supernatants, mixed lymphocyte responses may have resulted in 
the production of the immunosuppressive activity which could not be further 
increased by the addition of exogenous IL-2. Nevertheless, addition of Con A 
enhanced the suppressive activity of DCS (Fig. 5.3-1 &Table 5.3-2). This 
suggests that the suppressive factors are produced by Con A-sensitive cells 
or that they respond to stimuli produced by them.
The suppressive activity of the non-magnetic fraction of DCS was markedly 
decreased (Fig 5.5-2), despite approximately 25% of the cells being 
immunocompetent (Table 5.5-1). The majority of the cells in this fraction were 
non-immunocompetent and therefore unlikely to be the source of suppressive 
factors.
In terms of absolute numbers of NK cells, the suppressive activity of the non­
magnetic fraction was far less than that of the magnetic fraction, suggesting 
that other cells, rather than CD56+ NK cells, are likely to be responsible for
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producing the suppressive factors. However, the suppressive factor may 
need to reach a critical number before its effect is evident. Thus, NK cells can 
not be excluded as the source of the suppressive factors. Recently, Clark et 
al (1994) have reported that TGFp2-related immunosuppressive factors were 
produced by CD56+ NK cells in human first trimester decidua.
In summary, this study has identified 4-5 bands on SDS-PAGE which are 
associated with suppressive activity on cellular proliferation. Both of the
•to be.
LMWF and SMWF are uniikely^TGFp-like factors. The LMWF shows distinct 
differences to hDP200 and the SMWF appear to be distinct from PP14. 
Clearly the Identities of these factors needs to be established as do their 
cellular source(s).
6.3. FUTURE WORK
In order to clarify some of the findings there is a need to further purify the 
factors. Thus, the production of specific monoclonal antibodies to the factors 
observed by SDS-PAGE analysis would be the first step. These would be 
used to further purify the suppressive factors by affinity chromatography and 
to detect precisely which cell was producing them. Following isolation, the 
amino acid sequences of the purified factors could be determined and 
compared with other known immunoregulatory factors. Ultimately, probes 
could be developed to identify the genes responsible for the suppressing 
factors. A study could then be made of the possible role of these factors in
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recurrent abortion and other immunologically based diseases, especially 
those of an autoimmune nature, along with our increased understanding to 
the fetal-maternal immune relationship.
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APPENDIX:
REAGENTS, BUFFERS AND EQUIPMENT
7.1. SODIUM DODECYL SULPHATE - POLYACRYLAMIDE GEL 
ELECTROPHORESIS (SDS-PAGE)
30% acrylamide mix (with 0.8% bisacrylamide, 37.5:1.
from National Diagnostics)
Ammouium persulphate (10%, freshly prepared, from BDH) 
Butanol saturated with water 
Dithiothreitol (DTT, from Sigma)
Molecular weight standard (prestained, from Biorad)
SDS (Lauryl sulfate, from Sigma)
TEMED (N,N,N’,N'-Tetramethyl-ethylenediamide, from Sigma) 
Tris (Tris[hydroxymethyl] aminomethane, from Sigma)
Resolving buffer x4
Tris-HCI PH8.8 1.5M
SDS 0.4% (w/v)
Stacking buffer x4
Tris-HCI PH6.8 4% (w/v)
Resolving gel 12% 7.5%
water 20 ml 30 ml
30% acrylamide mix 24 ml 15 ml
4x resolving buffer 15 ml 15 ml
*10% ammouium persulphate 300 111 300 111
*TEMED 30 111 30 111
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5% stacking gel
water 13.9 ml
30% acrylamide mix 4.0 ml
4x stacking buffer 6.0 ml
*10 % ammouium persulphate 200 111
*TEMED 20 111
Sample buffer x4
Stacking buffer x4 2.4 ml
20% SDS 4 ml
Glycerol 4 ml
Bromophenol blue 0.01%
DTT (optional) 20 mM
Tank buffer xIO
SDS 1%
Glycine 0.55 M
Tris 0.5 M
* Added immediately before pouring.
7.2. DETECTION OF PROTEINS BY COOMASSIE BRILLIANT BLUE
Coomassie brilliant blue stain
Methanol: Acetic acid: Water 5:2:5
Coomassie blue 0.1%
Fix/Destain Methanol 30%
Acetic acid 10%
in MO water
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7.3. PROTEIN TRANSFER
Western blot transfer buffer
Tris 25 mM
Glycine 190 mM
Methanol 200 ml
Water to 1L
7.4. IMMUNOSTAIN
Primary antibody: diluted in TTBS with 3% BSA (Sigma).
Secondary antibodies (HRP-conjugated) : diluted in TTBS with 3% BSA. 
(Alternatively biotinylated secondary antibodies plus Extravidin (HRP- 
conjugated) were used).
Enhanced chemiluminescence (ECL) detection reagents 1 and 2 
(Amersham):
TTBS X5
Tris 250 mM
NaCI 2.5 M
PH 7.4
autoclaved
TTBS TTBSx5 200 ml
MQ water 800 ml
Tween 20 0.5 ml
Western blot blocking solution
Dried low fat milk 8% in TTBS
or BSA 3% in TTBS
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7.7. IMMUMNOLOGICAL REAGENTS
Conjugated MoAb against CD3(FITG), CD56(PE), GD16(PE), GD14(FITG) 
and HLA-DR(PE) (all from Becton Dickinson, Gowley, Oxford, UK).
Conjugated MoAb against GD16(FITG) (Eurogenetics, Teddington, Middx).
Extravidin (HRP-conjugated; Signal Chemical ltd, Poole, UK).
Goat anti hTGFI32 polyclonal neutralising antibody (R&D system; Abingdon, 
UK; Lot No. EE212).
Goat anti-rabbit IgG (Biotin conjugated. Signal Chemical ltd, Poole, UK).
Goat anti-rabbit IgG (HRP-conjugated; Signal Chemical ltd, Poole, UK).
hTGFBI (Becton Dickinson; Cowley, Oxford, UK. lot No. 900503 
and 911593).
Immunobeads (including CD3, CD4, CD8, CD14, GDI 6, CD56, and
negative NK cell isolation kit; all from Miltenyl Biotel GMbH, Germany).
Interleukin 2 (R&D System, Abingdon, UK).
Rabbit anti hTGFBI polyclonal neutralising antibody (Becton Dickinson; 
Cowley, Oxford, UK. Lot No. J792).
Rabbit anti-goat IgG (HRP-conjugated; Signal Chemical ltd, Poole, UK).
Rabbit pan anti hTGFB neutralising antibody (anti TGFB1 and B3; R&D 
system; Abingdon, UK; Lot No.E0033091).
Recombinant hTGFB2 (Crystal Chem, Chicago, USA; Lot No. CR 7-042).
7.5. RADIAL IMMUNODIFFUSION
0.3M Phosphate buffer:
KH2PO4 2.24 g
K2HPO4-3H2O 64.7 g
Distilled H2O 1.0 L
pH 8.0
1.5% Noble Agar in 0.3 M Phosphate buffer 
Antibodies (Sigma)
Goat anti-human IgG (y-chain specific; Lot 022H8808) 
Goat anti-human IgA (a-chain specific; Lot 50H8836) 
Goat anti-human IgM (ji-chain specific; Lot 28F-8920) 
Human serum (HS; Sigma; lot No. 53H0780)
7.6. PREPARATION OF PERCOLL
Percoll, 62.5%
Diluent, 37.5%
(45 ml 10x PBS 
3 ml 0.6 M HCI 
132 ml dH20
Sterilise through a 0.2 pm filter)
36% Percoll:
50% of 62.5% Percoll 
50% of RPMIc
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7.8. OTHER REAGENTS
Complete RPMI: RPMI supplemented with 10% PCS, 2mM L-glutamine, and 
100 pg /ml kanamycin (all from Signal Chemical ltd, Poole, UK). 
Concanavalin A (Sigma).
3-(4,5-dimethylthiazol-2-yi)-2,5 diphenyl tétrazolium bromide (Sigma). 
Lymphoprep (Nycomed, Birmingham, UK).
Mitomycin C (Sigma).
Phenol red-free RPMI medium (Gibco, Paisley, UK), 
phytohemagglutinin (ICN, High Wycombe, UK).
Propidium iodide (Sigma).
Prestained M.w. markers for PAGE analysis (Bio-Rad, California, USA). 
Protein M.w standards for chromatographic study (Sigma).
Sephacryl S-100 HR (Sigma).
Tritiated thymidine (specific activity 25 Ci/mmol; Amersham, 
Buckinghamshire, UK).
7.9. EQUIPMENT
Cell harvester (ILACON, Tonbridge, Kent, UK).
FACScan fiow cytometer (Becton Dickinson, Cowley, Oxford, UK).
High performance liquid chromatography (FPLC; Pharmacia, Sweden). 
Magnetic activated cell sorter (MACS; Miltenyl Biotel GMbH, Germany). 
Minitan ultrafiltration system (Millipore, Bedford, USA).
Ultracentrifuge (Beckman, UK).
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